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ABSTRACT 
Enrichment of Canine Gestation and Lactation Diets with n-3 Polyunsaturated Fatty Acids 
to Support Neurologic Development.  (August 2004) 
Kimberly Michele Heinemann, B.S., Texas A&M University 
Chair of Advisory Committee:  Dr. John E. Bauer 
 
 
 Long-chain polyunsaturated fatty acids (LCPUFA) are essential for proper neural 
and retinal development in many mammalian species.  One objective of this research was 
to investigate the effects of dietary α-linolenic acid (ALA) and LCPUFA on the fatty acid 
composition of canine plasma phospholipids (PL) and milk during the gestation and 
lactation periods.  The fatty acid composition of plasma PL and the retinal development of 
puppies reared on the same experimental diets as their mothers were also investigated.   
 Enriching the canine gestation/lactation diet with ALA (6.8% DM) does not result 
in enrichment of docosahexaenoic acid (DHA) in the milk.  From this data it can be 
inferred that peroxisomal elongation and desaturation of LCPUFA does not occur in canine 
mammary tissue.  Dose responses of linoleic acid (LA), ALA and DHA were observed in 
the plasma of adult dogs during gestation and lactation and in puppies during both the 
suckling and post-weaning periods.  Plasma PL fatty acid data from puppies indicate that 
canine neonates are capable of synthesizing LCPUFA from ALA, but that plasma 
enrichment of the newly-synthesized DHA does not compare with that obtained from 
preformed DHA in the diet.  
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Visual function was assessed via electroretinography (ERG) in 12-wk old canines.  
One-way ANOVA revealed significantly better visual performance in dogs fed the highest 
amounts of n-3 LCPUFA.  Puppies in this group demonstrated the greatest rod response as 
measured by the amplitude and implicit time of the a-wave.   Neonates reared on the 
lowest dietary levels of both ALA and n-3 LCPUFA exhibited the poorest visual function.  
A novel parameter devised in this study was the threshold intensity, which was the initial 
intensity at which the a-wave was detectable.  Again, puppies consuming the greatest 
concentrations of n-3 LCPUFA responded significantly sooner, i.e. exhibited greater rod 
sensitivity, than other diet groups. 
 The findings of this research underscore the importance of preformed n-3 LCPUFA 
in the diet, rather than ALA, as a means of enriching neural tissues in DHA during the 
developmental period.  Moreover, dietary DHA appears to be related to improved visual 
performance in developing canines. 
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CHAPTER I 
INTRODUCTION 
Essential Fatty Acids 
The n-3 and n-6 families of polyunsaturated fatty acids (PUFA) contain many 
biologically important lipids that are essential for proper growth, development and general 
adult health maintenance.  The parent fatty acids, alpha-linolenic acid (ALA, 18:3 n-3) and 
linoleic acid (LA, 18:2 n-6), are not synthesized in mammals and, thus, are deemed 
essential.  Since LA and ALA are not synthesized endogenously, they must be obtained 
from the diet.  Both fatty acids are of plant origin and can be found in a variety of plant-
derived oils.  Canola, sunflower, and safflower oils are but a few sources rich in LA while 
flaxseed oil is highly enriched in ALA.  These parent essential fatty acids (EFA) give rise, 
via elongation and desaturation pathways, to longer chain polyunsaturates that are essential 
for numerous physiological functions.  Moreover, the n-3 and n-6 fatty acids are 
functionally and metabolically distinct, and no interconversion occurs between the two.   
Essential fatty acids were considered of little importance in humans until the early 
1960s when indications of clinical deficiency became apparent in infants fed skim milk-
based formula and those administered lipid-free parenteral nutrition (1-2).  These infants 
experienced dryness, desquamation and thickening of the skin, growth faltering, and poor 
wound healing, which are typical manifestations of LA deficiency (3).   
Clinical deficiencies of all EFA are manifested in poor growth, skin lesions, 
degenerative changes in numerous organs, impaired water balance, increased fragility and 
permeability of cell membranes and increased susceptibility to infection (4).  
                                                 
  This dissertation is in the style and format of Lipids. 
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Administration of diets containing 2% or more of total calories as LA relieves these 
clinical signs (1).  While general EFA deficiency may be easily recognized, those of n-3 
fatty acid deficiency alone are subtler and include decreased visual acuity and 
electroretinogram amplitudes, peripheral neuropathy and reduced learning ability (5).  
Thus, nervous system signs associated with EFA deficiency are most likely the result of an 
absence of the long chain metabolic derivative of ALA, namely DHA.  At times the 
measurements of neurologic functions are difficult to ascertain; instead, concentrations of 
docosahexaenoic acid (22:5 n-3, DHA) can be analyzed in serum lipids, erythrocyte 
membranes, and platelets.  These measures often are regarded as indices of DHA status.   
Essential fatty acids serve as substrates for a series of enzymatic reactions that 
convert them to 20-carbon fatty acids, which in turn are precursors for eicosanoid 
synthesis.  Eicosanoids are a group of potent, short-lived biological compounds that are 
derived from the 20-carbon fatty acids arachidonic acid (20:4 n-6, AA) and 
eicosapentaenoic acid (20:5 n-3, EPA) (Figure 1.1).  Eicosanoids act locally as hormones 
and include prostaglandins, leukotrienes and thromboxanes (6).   Generally, those 
eicosanoids derived from AA tend to mediate inflammatory and immune responses such as 
platelet aggregation, vasoconstriction, and increased blood viscosity.  On the other hand, 
EPA-derived eicosanoids tend to be anti-inflammatory in nature, and as a whole, less 
potent than their n-6 analogs. The general effects of n-3 eicosanoids include decreased 
platelet aggregation, vasodilation, and reduced blood viscosity.   
Both n-6 and n-3 fatty acids utilize the same set of enzymes for conversion to 
eicosanoids; thus, the synthesis of one group relative to the other depends upon the relative  
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Figure 1.1  Schematic diagram of eicosanoid synthesis from AA and EPA.  The 
two classes of eicosanoids exert properties that are antagonistic to one another.  
Eicosanoids derived from AA exert potent pro-inflammatory effects whereas those derived 
from EPA exert less potent inflammatory and thrombotic effects and are therefore 
considered anti-inflammatory in nature (7). 
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amounts of precursors present.  A diet high in n-6 fatty acids will generally increase 
production of pro-inflammatory compounds and shift the physiological state to one that is  
pro-thrombotic and pro-aggregatory (7).  As a result of such a shift, blood viscosity 
increases and bleeding time decreases (7).  Conversely, a diet rich in fish oil, an excellent 
source of long chain n-3 fatty acids, mediates an overall anti-inflammatory response 
manifested by the production of weak platelet aggregators and weak vasoconstrictors that 
are, in effect, biologically inactive (7).  Whereas the n-6 series eicosanoids directly 
influence inflammation, the n-3 series does so in a somewhat indirect manner.  Rather than 
exerting direct inhibitory effects, they produce an overall anti-inflammatory effect via the 
decreased synthesis of n-6 eicosanoids and the increased synthesis of essentially inactive 
compounds.     
Further elongation and desaturation of EPA yields the neurologically important 
docosahexaenoic acid (22:6 n-3, DHA).  In recent years, evidence has amassed which 
asserts the essentiality of DHA for optimal neural and retinal development in neonates.      
Fatty Acid Nomenclature 
Fatty acids are identified by their chain length and by the numbers and positions of 
their double bonds.  For example in ALA, an n-3 fatty acid with 3 double bonds, the first 
double bond occurs at the third carbon from the methyl terminus, hence the term n-3 fatty 
acid.  Similarly, in n-6 fatty acids, the position of the first double bond is 6 carbons from 
the methyl terminus.   
Fatty acids with 2 or more double bonds are considered polyunsaturated fatty acids 
(PUFA), and fatty acids 20 carbons or more in length are considered long chain 
polyunsaturated fatty acids (LCPUFA).  The double bonds in fatty acids of mammalian 
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origin are 1, 4-conjugated dienes, and all double bonds are in the cis conformation.  
Insertion of subsequent double bonds proceeds through the action of one of the 3 
mammalian desaturases—∆9, ∆6, or ∆5—and maintains the methylene-interrupted pattern 
of double bonds.  Beginning with the first double bond from the methyl terminus, one can 
deduce the positions of all other double bonds by following this pattern.   
The liver is the primary site of LCPUFA synthesis, which occurs on the 
endoplasmic reticulum via an alternating sequence of desaturation and elongation reactions 
(Figure 1.2).  If LA or ALA is the substrate for desaturation, the ∆6 desaturase enzyme 
inserts a double bond 6 carbons from the carboxyl terminus, thus generating 18:3 n-6 or 
18:4 n-3, respectively.  This is followed by elongation and subsequent desaturation to yield 
the 20-carbon derivatives AA and EPA.  Until recently, the synthesis of DHA from EPA, 
and docosapentaenoic acid (22:5 n-6, DPA) from AA, was thought to occur via elongation 
and the action of a ∆4 desaturase.  No evidence, however, for such a pathway in mammals 
presently exists (reviewed in 8).  Instead, Sprecher (8) proposed that conversion beyond 
EPA takes place by way of 2 consecutive elongation reactions to yield 24:5 n-3, which 
becomes the substrate for a second ∆6 desaturase.  Some evidence suggests that this ∆6 
desaturase is different from the one that catalyzes the first desaturation reaction in the 
pathway (9).  The resultant 24:6 n-3 then undergoes retroconversion to DHA.  This 
retroconversion involves a partial beta-oxidation, which takes place within the peroxisome 
rather than in the mitochondria (11) (Figure 1.2).   Additionally, some studies indicate that 
the elongation, and subsequent desaturation and retroconversion, of 22:5 n-3 (DPA n-3) is 
the rate-limiting or regulatory step in the synthesis of DHA (12).  An analogous pathway 
exists for the conversion of AA to DPA n-6 (13).   
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Figure 1.2  Metabolic conversion of essential fatty acids (EFA) to form LCPUFA.  
Parent EFA of both the n-3 and n-6 series are derived from dietary sources.  Elongation 
occurs two carbons at a time and desaturases introduce double bonds from the carboxyl 
terminus of the original fatty acid.  The final step in the formation of n-3 and n-6 end 
products is catalyzed by a peroxisomal partial beta-oxidation (figure modified from 
reference 10).   
 7
In order to elucidate the mechanism of DHA synthesis, Sprecher (8) first incubated 
1-14C labeled 22:5 n-3 with rat liver microsomes and did not observe any radiolabeled 
DHA products.  However, the elongation products 24:5 n-3 and 24:6 n-3 were observed 
when malonyl Co-A and NADPH were added to the incubation.  It was presumed that this 
elongation occurred by a ∆6 desaturase.  Then, the same labeled substrate was incubated 
with rat liver hepatocytes and produced not only labeled DHA, but small amounts of 24:5 
n-3 and 24:6 n-3 as well.  In an additional study, fibroblasts that lacked peroxisomes, a 
condition of Zellweger’s disease, were incubated with 3-14C labeled 24:5 n-3 (8).  
Interestingly, the desaturation product, 24:6 n-3, was present, but DHA was not.  This was 
in contrast to data from control fibroblasts in which labeled DHA was found, thus 
indicating that the final conversion to DHA occurred by way of a peroxisomal beta-
oxidation pathway (14).   
Initially the proposed pathway of Sprecher was met with much controversy and 
skepticism.  However, no experimental evidence to date supports a conclusion contrary to 
that proposed by Sprecher and colleagues (8).  In fact, results from newer studies further 
reinforce the concept of peroxisomal beta-oxidation (15-17). 
Fatty Acid Metabolism in the Neonate 
It is well known that the human fetus and neonate can desaturate and chain-
elongate 18-carbon precursors to their respective LCPUFAs (18-22).  The uncertainty, 
however, lies in whether the rate of synthesis is enough to meet the demands for optimal 
growth and development.  A number of studies have reported insufficient desaturase 
activities in human fetuses, especially during the last 2 weeks of gestation (19,23-25).  This 
information raises the additional concern of whether pre-term infants are at greater risk for 
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LCPUFA insufficiency than are term infants since, at birth, preterm infants are deprived of 
their intrauterine EFA supply (26).  Studies by Farquharson (27) and Innis (28) indicate 
that no difference exists between the preterm and term infant in their ability to convert LA 
and ALA to their long-chain metabolites.  Moreover, Uauy (29), in agreement with Salem 
and others, suggests that LCPUFA formation, in fact, may be more active at earlier 
gestational ages.   
Because the placenta itself does not desaturate LA or ALA, the human fetus must 
acquire most of its fatty acids via placental transfer.  Thus, the primary determinant of fatty 
acid delivery to the fetus is the concentration in the maternal circulation, which is closely 
related to maternal fatty acid intake (30).  At the fetal-maternal interface, there is a three-
fold difference in the concentrations of plasma non-esterified DHA (31).  Haggerty et al.. 
(32) demonstrated the preferential transfer of DHA relative to other LCPUFA in utero.  In 
their study, DHA was transferred at a rate 3 times higher than that of AA.  This same 
group attributed the specificity of the uptake system to a selective retention of AA in the 
placental tissue.   
A number of studies have attempted to explain the discrepancy in the rates of 
placental LCPUFA transfer.  It is believed that the mechanism involves the preferential 
binding of AA to a placental plasma membrane fatty acid binding protein (p-FABPpm) (32-
35).  The p-FABPpm is located on the maternal-facing placental membrane, which accounts 
for the unidirectional flow of LCPUFA from the mother to the fetus (33,36).  This notion is 
supported by evidence obtained in vitro, which shows a strong preference of p-FABPpm for 
AA and DHA (37).  Additionally, results from studies involving human placental cell lines 
indicate that DHA is incorporated into triacylglycerols (TAGs) and is then liberated by the 
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action of lipoprotein lipase before being transferred to the fetus (38).  Alternatively, AA 
primarily is acylated into phospholipids that accumulate within the placental tissue (37,39). 
The liver, which accumulates DHA during fetal life, also plays an integral role in 
the accretion of DHA in the neural tissues both in utero and postnatally.  Postmortem 
studies of human fetuses of varying gestational ages indicate that the parabolic rise of fetal 
liver DHA is paralleled by an increase in acylated DHA in the brain (40).  After birth, the 
levels of acylated DHA in the liver and adipose tissue decrease, concomitant with a 
continued increase of acylated DHA in the brain and retina (40-41).  Thus, adipose and 
liver tissues act as “sinks” that sequester DHA in utero in order to provide a reservoir of 
DHA during early postnatal life.   
DHA and Neural Development 
In humans and in animals, brain and retinal functions are dependent upon the n-3 
polyunsaturate DHA not only during development in utero, but during postnatal life as 
well.  The period of maximum brain growth begins in the third trimester of gestation, 
peaks at birth, and continues throughout the first eighteen months of neonatal life (42-45).  
It is during this crucial period that the brain undergoes a ten-fold increase in size (46), and 
selective accumulation of AA and DHA within the brain and retina occurs.  During this 
significant accrual of DHA, termed the “DHA accretion spurt,” the accretion of AA and 
DHA in brain and retinal phospholipids proceeds at a rate ten times faster than 
incorporation via chain elongation and desaturation of their respective precursors, LA and 
ALA (47-48). 
In human retina, DHA accumulation begins around the start of the third fetal 
trimester and peaks at the 40th gestational week (49-50).  The occurrence of n-3 fatty acid 
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deficiency during this developmental accretion phase results in decreased retinal DHA 
content (51-53), which subsequently manifests itself in decreased visual and neural 
function (43,51,54).  Once neural development is complete, a deficiency of n-3 fatty acids 
does not significantly affect the DHA content of the retina (52-53).  It is important, 
however, to note that although n-3-deficient subjects are able to obtain normal DHA levels 
upon repletion, the functional abnormalities resulting from early n-3 deficiency are not 
corrected upon repletion (5).   
The primary site of DHA accretion in neural tissues is the phospholipid (PL) 
fraction of brain and retinal cells (55-60).  The rod photoreceptor outer segment (ROS) 
contains the highest concentration of DHA within the body; approximately 50% of the 
fatty acids in the ROS plasma membrane phospholipids are DHA (58,61).  Within the 
phospholipid subfraction, DHA is usually esterified at the sn-2 position, but supraenoic 
molecules, in which DHA is esterified at both the sn-1 and sn-2 positions, also exist (57-
60,62-64).  Phosphatidylserine (PS) and phosphatidylethanolamine (PE) typically contain 
high levels of di-polyenoic species whereas phosphatidylcholine (PC) contains more 
saturated, monoenoic- or dienoic species than dipolyenoic species (59,63,65,66).  
Aveldaño (67) reported that the PL species most closely associated with the visual pigment 
rhodopsin, namely PC and PS, have greater amounts of DHA than other PL fractions.  
Furthermore, the interaction of rhodopsin with retinal PL is key in the control of visual 
function (68-70). 
The ROS is a dynamic structure consisting of thousands of plasma membrane 
invaginations that form disks of phospholipid bilayers and that contain rhodopsin and other 
enzymes of the visual cascade.  Adjacent to the ROS is the retinal pigment epithelium 
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(RPE), which provides the metabolic support for the photoreceptors (71,72).  Additionally, 
the RPE plays an integral role in the regeneration of visual pigments after photoreceptor 
bleaching, a process in which 11-cis-retinal is photo-isomerized to all-trans-retinal (73).  
Furthermore, and perhaps most importantly, the RPE maintains the supply of DHA to the 
ROS and aids in the retinal conservation of DHA (74-78) (Figures 1.3 and 1.4). 
Two possibilities exist for the mechanism by which the ROS becomes enriched 
with DHA:  1) there is a selective uptake of pre-formed DHA from the plasma or 2) the 
retina itself synthesizes DHA via the elongation and desaturation of ALA.  The conversion 
of ALA to DHA has been reported in RPE, but not in retina, of frogs (79).  Li et al. 
demonstrated that orally-administered, radiolabeled DHA, but not ALA was taken up by 
the rat retina (80).  Other studies have confirmed that plasma DHA is the preferred 
substrate for the retina during early development (81-83).  Anderson and Wang 
demonstrated that this enrichment occurs at both the plasma-RPE and RPE-photoreceptor 
boundaries (84).  In this study EPA was incorporated into PL in the RPE, but not in the 
ROS, which suggested that the RPE-photoreceptor boundary is one site of exclusion of 20-
carbon PUFA from the ROS.  Furthermore, they showed that the enrichment of 22-carbon 
PUFA within the retina is specific not only for chain length, but also for the number of 
double bonds (85).   
Given the extreme importance of DHA in retinal function, a mechanism must be in 
place to preserve its integrity within the neural tissues.   Indeed, this task is accomplished, 
in part, by the RPE (75,78).  Circulating lipoproteins also play a role in establishing and 
maintaining high levels of DHA within the photoreceptors (86).  New photoreceptor disks 
are continually being assembled at the base of the ROS, which results in a lengthening of  
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Figure 1.3  Schematic diagram of the eye.  Inset shows the structural organization 
of the retina (87). 
 
 
 
Figure 1.4  Schematic diagram of the photoreceptors (87).
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the ROS as older disks are pushed apically (75).  To compensate for this continual 
elongation, the distal portion of the ROS is shed and phagocytized daily by the RPE, and 
DHA then is shuttled back to the ROS in an efficient recycling loop (88) (Figure 1.5).  
Specifically, Bazan et al. (75) demonstrated that the RPE cells are directly involved in a 
short-loop recycling of DHA from the phagosomes within the RPE back to the rod inner 
segments via the interphotoreceptor matrix.  In later studies, this same group reported that 
phagocytosis triggered the expression of peroxisome proliferator-activated receptor-γ 
(PPARγ) (89,90), a fatty-acid activated transcription factor that contributes to lipid 
accumulation (91,92) and that DHA was stored transiently in TAGs within the RPE before 
being shunted back to the ROS (93).  Taken together, these data are evidence for a 
mechanism that provides for the strict conservation of DHA within the retina, even during 
periods of extreme n-3 fatty acid deficiency (56,94). 
The Visual Process 
The process of visual signal transduction involves a member of the biochemically 
ubiquitous G-protein-coupled motifs.  Receptors in the superfamily of G-proteins are 
integral membrane proteins consisting of seven transmembrane helices and their respective 
connecting loops.  The G-protein and effector proteins are, on the other hand, peripheral 
proteins, which are bound to the membrane via isoprenoid chain-lipid bilayer interactions 
(95,96) and electrostatic forces (97).  Because the ligand-binding site on the receptor is 
formed by transmembrane helices, the conformational changes accompanying receptor 
activation would be, expectedly, dependent upon the physical properties of the membrane 
lipid bilayers (98).  Indeed, high concentrations of DHA-derived n-3 PUFA have been 
observed in membranes with significant amounts of G-protein-coupled activity (64,100). 
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Figure 1.5  Diagrammatic representation of ROS shedding and phagocytosis by 
RPE.  New photoreceptor discs are continually assembled at the base of the ROS as older 
disks are pushed apically (stages 1-3).  The distal portion of the ROS is shed and 
phagocytized daily by the RPE (stages 4-6) as DHA is shuttled back to the ROS. (Figure 
modified from reference 99).
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 Rhodopsin is an integral membrane protein that spans the ROS disk membrane; it is 
the receptor protein in the visual transduction cascade (Figure 1.6).  The essential 
photoactive unit of rhodopsin consists of a molecule of 11-cis-retinal bound to opsin.  
Transducin, the G-protein, and its effector protein, cGMP phosphodiesterase (PDE), are 
the activation proteins, and are bound to the membrane by fatty acids (101-103).  The 
absorption of light by 11-cis-retinal results in its isomerization to all-trans-retinal and its 
subsequent dissociation from opsin (73).  Following this dissociation, rhodopsin exists as 
an equilibrium mixture of the active conformation of metarhodopsin II (MII) and the 
inactive conformation, metarhodopsin I (MI) (reviewed in 98).  Each MII activates 
hundreds of transducin (Gt) molecules, which in turn activate PDE, a cGMP-dependent 
effector enzyme.  Activated PDE catalyzes the hydrolysis of cGMP, which triggers the 
closure of cGMP-gated Na+/Ca+2 channels and leads to the hyperpolarization of the ROS 
plasma membrane and the visual response (Figures 1.7 and 1.8).  
The Effect of DHA in the Membrane   
The ease with which signaling proteins can traverse the membrane dictates the 
efficiency of the visual transduction cascade.  In order for phototransduction to occur, MII 
and Gt must find each other through lateral diffusion in the surface of the ROS membrane.  
Clearly, a more fluid membrane would better facilitate this process.  Indeed, it has been 
reported that the rate of rod phototransduction is determined by the lateral diffusion of the 
visual proteins within the membrane (104).  What, then, is the significance of DHA within 
biological membranes? 
  The prevalence of DHA within the PL species of the ROS suggests that a highly 
fluid membrane permits rapid enzyme action and ion transport (68,105).  Studies by  
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Figure 1.6  Schematic diagram of rhodopsin within the ROS disc membrane.  The 
characteristic seven transmembrane domains of the G-protein receptor and the site of 
retinal attachment are shown (99). 
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Figure 1.7  Schematic representation of visual transduction cascade.  The three 
proteins involved in the G-protein-coupled signal transduction of the visual system are 
shown in relation to the ROS disc membrane.  Rhodopsin is a transmembrane protein; the 
G protein, transducin or Gt, and the effector, cGMP phosphodiesterase or PDE, are bound 
to the membrane surface.  Light converts rhodopsin to an equilibrium mixture of an 
inactive form, MI and an active form MII.  MII binds and activates Gt (GDP) by catalyzing 
the exchange of bound GDP for GTP.  Gt (GTP)* then dissociates and Gtα(GTP)* binds to 
the inactive form of PDE.  This complex dissociates to yield the active subunit complex 
PDEαβ*, which hydrolyzes cGMP.  The lowered concentration of c-GMP induces closure 
of cGMP-gated sodium channels in the plasma membrane, hyperpolarizing the cell (98). 
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Figure 1.8  Cartoon representation of the visual phototransduction cascade (87).
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Litman and Mitchell (106,107) confirmed this notion and have provided much insight into 
the relationship between membrane fluidity and signal transduction.  They demonstrated, 
in reconstituted membrane systems, that the highest levels of MII formation occurred in 
bilayers that contained DHA within the PL.  Additionally, in native ROS disks, MII 
formation is followed rapidly by formation of the MII-Gt complex, which makes the 
process of visual signal transduction rather efficient.  Also, as the bilayer acyl chains 
become more saturated, phototransduction is delayed (106, 107). The presence of 
cholesterol within the membrane provides additional impedance to the formation of MII.   
More recent studies indicate that the functional consequences of polyunsaturated 
PL extend beyond the MI to MII transition to the rapid coupling of receptor and G-protein 
and to the functional efficiency of the receptor (98).  In simulated cellular responses, a 
membrane with a content of DHA or DPA n-3 PL acyl chain equivalent to that in a healthy 
rod cell produces a response similar to that recorded in vivo, whereas a membrane in which 
n-3 is replaced by DPA n-6 produces a much slower response.   
These alterations in PL acyl chains of the ROS offer, at least in part, an explanation 
for the functional abnormalities observed in the electroretinograms (ERG) of n-3-deficient 
animals, which will be elaborated upon later in this chapter.  The increased lag time in 
MII-Gt coupling in less-unsaturated membranes correlates to the lag time in the ERG, and 
the reduced formation of MII explains the decreased signal amplitude in n-3-deficient 
retinas (98,108). 
The Electroretinogram 
Electroretinography is a sensitive and quantitative measure of retinal function in 
humans and animals.  The ERG recording represents the response of the photoreceptors, 
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and their subsequent post-synaptic signals, to a series of varying-intensity flash stimuli.  It 
is the sum of responses across the retina and includes the responses of many retinal cell 
types.  The leading edge of the negatively projecting curve is the a-wave; its amplitude is 
measured from the baseline to the trough of the wave (Figure 1.9).  The a-wave is a 
measure of photoreceptor function and can be further divided into slow and fast comp1nts 
(109).  Early studies in rats determined that the photoreceptor layer is the origin of the a-
wave, and that it results from extracellular radial current (reviewed in 109) (Figure 1.10).  
In other words, the a-wave reflects the reduction in ‘dark’ currents due to light absorption 
in the photoreceptor outer segments and the closure of c-GMP-gated channels (109).  The 
slow comp1nt of the a-wave is indistinguishable in the standard ERG, as it is masked by 
the large amplitude of the c-wave (for c-wave details, see 109).  However, upon isolation 
of the a-wave, it was determined that the slow response originates from the Müller cells 
(110).  Light absorption by the photoreceptors causes a reduction in the extracellular 
potassium ion concentration, which results in alterations in the trans-membrane potential 
of the Müller cells and is visible as the a-wave. 
 The positively projecting comp1nt of the ERG is the b-wave; its amplitude is 
measured from the trough of the a-wave to the peak of the b-wave.  The b-wave has been 
the focus of most ERG research since it is the major parameter of interest when assessing 
human retinal function.  Early research pinpointed the retinal cells that are post-synaptic to 
the photoreceptors as the origin of the b-wave, although the exact cellular source remains 
disputed (109).  Consequently, the b-wave can be eliminated by any procedure or 
substance that blocks synaptic transmission from the photoreceptors.  A more extensive  
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Figure 1.9  Example of ERG recording.  The amplitudes of the a- and b-waves are 
indicated by ‘a’ and ‘b,’ respectively.  The implicit times of respective waves are denoted 
La and Lb (109). 
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Figure 1.10  Cartoon of the retina showing the origin of the major ERG waves.  
The a-wave originates in the photoreceptors, and the b-wave originates in the post-synaptic 
neurons.  The c- and d-wave and oscillatory potentials (OPs) are minor comp1nts and are 
not of interest in this research (109). 
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discussion of the b-wave and related studies can be found elsewhere and is beyond the 
scope of this review (109). 
 For a more thorough examination of rod function, multiple recordings can be 
obtained in response to a series of flashes of increasing intensity that covers the range from 
rod threshold to b-wave saturation (111).  Additional parameters can also be evaluated.  
These include the a- and b-wave implicit times and the a-wave to b-wave ratio.  The 
implicit times are measured from the time of stimulus onset to the peak, or trough, of the 
corresponding wave (Figure 1.9).  The c-wave, which is of little use clinically, is discussed 
in detail elsewhere (109).    
Studies of DHA and Visual Development 
 In the last twenty years, the importance of n-3 fatty acids in brain and retinal 
development has become increasingly evident.  The question still remains, however, 
whether ALA provided as a precursor is sufficient for optimal development or if preformed 
DHA is required.  The greatest concern is for premature infants, whose intrauterine 
development is cut short, often by several weeks (26).   
 As menti1d previously, neural development in primates begins in the third trimester 
of gestation, peaks about the time of birth, and continues for about 18-24 months after 
parturition (42-45).  During this developmental period, AA and DHA are rapidly 
incorporated into the neural tissues (46-48).  The high levels of DHA in the brain and 
especially in the retina suggest a functional role in these tissues (108). 
Term Infants   
Numerous studies have attempted to evaluate the effects of human milk LCPUFA 
in breast-fed term infants on visual acuity and other developmental and functional tests.  
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The results are, at best, equivocal, and the debate continues as to whether or not LCPUFA 
supplementation of term-infant formula is necessary.   
 In one study term infants were fed a formula containing 2.1 wt% of total fatty acids 
as ALA and then outcomes of visual acuity tests were compared to those of breast-fed 
infants (112).  At 3 months of age, no differences in visual acuity, as measured by Teller 
forced-choice preferential looking, were found between groups.  Several studies by 
Auestad and coworkers confirmed these findings.  Infants who were breast fed or fed 
formula supplemented with DHA and AA displayed no developmental advantage over 
those infants who were fed standard formula (113-115).  Infants in the supplemented 
formula and breast fed groups did have similar levels of DHA and AA in their plasma and 
RBC, which were higher than non-supplemented infants, but there were no differences 
among all groups in any of the developmental parameters assessed (115). 
 Contrary to these findings are the results of numerous other studies.    Makrides et 
al. reported marked functional differences between infants who were breast-fed and those 
who were fed standard, non-supplemented formula.  In one study, they found increased 
visual evoked potential (VEP) acuity in breast-fed compared to formula-fed infants and 
noted a correlation between VEP and erythrocyte DHA content (116).  In a separate 
experiment, they randomized infants to non-supplemented formula or to formula 
containing 0.36 wt% of total fatty acids as DHA and compared them to breast-fed infants.  
They again found an increased VEP acuity at 15 and 30 weeks of age in breast-fed and the 
DHA-formula fed groups compared to the non-supplemented group (117). 
 Similarly, another study reported significantly higher visual acuity at 2 months and 
again at 4 months in breast-fed infants compared with those who received a formula 
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containing 1.7 wt% of fatty acids as ALA (118).  Carlson and coworkers reported a 
difference in visual acuity at 2, but not at 4, months in infants fed either a non-
supplemented formula or a formula containing 0.1% DHA (119).  Birch et al., however, 
reported superior visual acuity, as measured by both VEP and forced-choice preferential 
looking, in breast-fed compared with corn oil-based formula-fed infants (120). 
 Makrides and coworkers reported conflicting results between 2 trials in which the 
effects of dietary fatty acids on visual acuity were assessed (121,122).  One study reported 
no effect of dietary intervention, in the form of varied LA/ALA ratios, in 16-week old 
infants.  Contrary to this report was one in which they found improved visual acuity in 
LCPUFA supplemented infants compared to non-supplemented infants.  In light of these 
results, they conducted a retrospective analysis in an attempt to pinpoint some of the 
indicator variables of visual acuity in healthy, term infants at 16 weeks of age (123).  They 
reported no effects of DHA status near birth on VEP acuity; they suggested that infants 
born with higher DHA levels may be less responsive to alterations in dietary fatty acid 
supply.  Their data do not support the notion that n-3 LCPUFA status at birth is a 
significant predictor of visual outcome.  Moreover, this analysis reported that numerous 
other factors, including birth weight, gender and social and demographic characteristics 
should be considered when evaluating VEP acuity. 
Pre-term Infants   
The case for the LCPUFA supplementation of premature-infant formula seems to 
be much stronger than the case for term-infant formula supplementation.  Most studies to 
date report a positive effect of n-3 LCPUFA supplementation on measures of DHA status 
and on visual acuity and function.   
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 Hoffman et al. evaluated the effects of n-3 LCPUFA on retinal and cortical 
development in premature infants (124).  Infants in their study received breast milk, either 
a corn-oil- or soy-oil-based formula or a marine-oil-supplemented formula from 10 days of 
life until 57 weeks post-conceptional age (PCA).  The breast milk and marine-oil-
supplemented groups had similar erythrocyte LCPUFA profiles, which were superior to 
those of the corn-oil group at 36 and 57 weeks PCA.  The marine-oil and breast milk 
groups had significantly higher levels of DHA in erythrocyte PL than did the corn-oil 
group.  Additionally, the corn-oil group had impaired visual acuity, as measured by VEP 
and preferential-looking, at these same time points.  They also had less mature rod function 
at 36 weeks PCA, which was manifested in higher rod thresholds and lower ERG a-wave 
amplitudes compared to the breast-fed and marine oil groups.  
 In a 1993 study conducted by Carlson et al.(125), preterm infants who received an 
EPA-supplemented formula containing 0.2% DHA and 0.3% EPA had better visual acuity 
at 2 and 4 months of age.  Beyond 4 months of age, the level of visual function in 
supplemented infants was matched by the control infants.  In a separate set of later studies, 
preterm infants were given a standard preterm infant formula containing 3% ALA or the 
same formula supplemented with 0.02% DHA and 0.06% EPA for up to 2 months (126) or 
up to 9 months (127).  After the supplementation period, all infants were given the 
standard formula with 3.0% ALA as the sole source of n-3 fatty acids.  The DHA-
supplemented infants in both studies had shorter look durations than infants on the control 
formula.  Shorter look duration and visual acuity are both positive neural outcomes of 
DHA supplementation in premature infants (127).  Interestingly, the DHA group also 
displayed a 10-point advantage in IQ at 12 months post-supplementation, indicating a 
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long-term effect of short-term supplementation of dietary DHA during infancy.  The 
standard formula in this study contained 3.0% ALA, and the infants assigned to it had the 
poorest DHA status, which further strengthens the argument that DHA is conditionally 
essential for neural development in preterm infants. 
 In the studies menti1d thus far (125-127), the low levels of EPA did not adversely 
affect AA status or infant growth.  However, a study in which preterm infants received 
standard formula or a supplemented formula with a DHA/EPA ratio of 2/3, the 
supplemented infants exhibited lower growth parameters (128).  More recent data from 
Rodriguez et al. (129) suggests that preterm infant formula containing DHA and EPA in a 
ratio of 5:1 in combination with 0.6% energy as ALA is compatible with growth and 
proper n-3 fatty acid metabolism.  In this study, supplemented infants maintained the same 
erythrocyte DHA and AA status as breast-fed infants, and infant weight, height and head 
circumferences were not different between groups.  
Animal Studies 
Many non-human species have been used as models for studying the effects of 
dietary n-3 content on retinal function.  In particular, rhesus monkeys are an ideal model 
for human retinal function because of the many similarities between the structure, function 
and development in the retina (130-134).  Only higher primates have a fovea that enables 
high visual acuity in addition to 3 classes of cones that enable trichromatic vision (130).   
 Neuringer and colleagues have conducted numerous studies involving the DHA 
status of n-3-deficient rhesus monkeys.  They showed that monkeys that were born to n-3-
deficient mothers and then were reared on an n-3-deficient diet after birth developed low 
amounts of n-3 fatty acids in brain and retina and displayed impaired visual function 
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compared to controls (5,51,135).  Specifically, they noted a sharp decline in cerebral cortex 
DHA along with a compensatory increase of 22:5 n-6.  The sum total of n-6 and n-3 PUFA 
in the PL was relatively unchanged, indicating a mechanism exists within the brain that is 
aimed to conserve the polyunsaturation of the membrane PL despite the state of n-3 
deficiency.  In the n-3-deficient animals, the impairment of visual function was indicated 
behaviorally by decreased visual acuity and in the ERG by delayed recovery of a dark-
adapted response to a saturating flash.  Interestingly, the a-wave and b-wave amplitudes 
were unaffected by n-3 deficiency, but the implicit times of both the a- and b-waves were 
significantly increased in n-3-deficient monkeys (136).  An additional study reported that, 
even when DHA was replete, the abnormalities in the ERG persisted (137).  These results 
further underscore the importance of n-3 PUFA, and particularly DHA, during the perinatal 
period. 
 In follow-up studies of juvenile rhesus monkeys, Connor et al. (138) reported a 
rapid repletion of DHA in the cerebral cortex to control levels or above control levels when 
animals deficient since intrauterine life were fed a fish oil diet high in EPA and DHA.  The 
recovery of neural DHA began within a week of fish oil feeding and was complete within 
12 weeks.  Again, the sum total of n-3 and n-6 fatty acids remained quite similar, and the 
increase in n-3 PUFA was accompanied by a reciprocal decline in n-6 PUFA. 
 Jeffrey et al. (139) investigated the effects of LCPUFA supplementation on visual 
acuity and retinal function in infant rhesus monkeys as well.  They formulated the 
experimental diets to contain both DHA and AA in markedly greater quantities, 1.0% each 
of total fatty acids, than those used in previous human studies.  They measured 25 
parameters of visual function and found a significant diet effect in only 2.  The failure to 
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detect significant differences between subject groups suggested that an upper limit exists 
for the developmental and functional benefits of LCPUFA supplementation and that the 
high concentrations of DHA and AA neither harm nor benefit the development of visual 
function at 4 months of age. 
A recent study in preterm baboons reported a close, linear correlation between 
retinal DHA status and a-wave parameters (140).  Traces from 4-week old premature 
baboons fed either non-supplemented formula or formula supplemented with 0.6% energy 
AA and 0.3% energy DHA showed significantly smaller a-wave amplitudes and longer a-
wave implicit times than full term, breast-fed neonates.  Although the supplemented 
premature infants performed better than their non-supplemented counterparts, the level of 
retinal function did not match that of the breast-fed term group.  Moreover, b-wave 
amplitudes only slightly responded to increased retinal DHA in the formula groups.  In 
addition, retinal AA concentrations were unaffected by either prematurity or 
supplementation.   
Rats and guinea pigs have also been used as models for human retinal function.  
Early studies of retinal function in rats showed that, contrary to data from monkeys, ERG 
amplitudes were indeed affected by dietary n-3 fatty acids (141,142).  Rats that were fed 
ALA had larger a-wave amplitudes than did deficient rats.  However, Leat et al. (143) 
raised rats and guinea pigs to a third generation on n-3-deficient diets and reported no 
differences in b-wave amplitudes between deficient animals and those reared on 
commercial diets.  Further support for these results came from Bourre et al. (54) who 
observed diminished a- and b-wave amplitudes in young rats fed ALA-deficient diets.  
They also suggested that the effects on the b-wave were transient while the effects on the 
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a-wave persisted into adult life.  These data are, again, in contrast with those reported in 
monkeys by Connor and Neuringer (137), which indicate that n-3 repleted monkeys do not 
regain retinal functionality as measured by ERG.  To further confound the issue, data from 
n-3-deficient guinea pigs show complete functional recovery in ERG parameters after ten 
weeks on an n-3 fatty acid-replete diet (144).  The ERG of the guinea pig is biphasic, 
rather than the roughly sigmoidal curve observed in rat and human ERG (143).  
Furthermore, the guinea pig retina can be made nearly devoid of any DHA, whereas rats 
and primates tenaciously retain retinal DHA (74-78).  Thus, species differences may 
account for the discrepancies among studies in primates and rodents.  Consequently, data 
from such studies should be considered cautiously before making extrapolations to 
humans.   
LCPUFA Supply in Maternal Milk 
After parturition, maternal milk serves as the sole exogenous source of LCPUFA 
for the newborn.   The concentration of DHA in human milk varies more than 10-fold and 
is dependent upon the mother’s diet (145).  DHA levels in the breast milk of most Western 
populations reach about 0.1-0.4% of total milk fatty acids (146), whereas in regions with a 
high fish consumption that amount can be up to 1.4% (147-149).  Jørgensen et al. (150) 
reported that, within the Danish population al1, milk DHA levels varied by more than a 
factor of 10, and 55% of that variation could be explained by the differences in maternal 
fish intake.  Thus, since 30% of the individual fatty acids in maternal milk are derived 
directly from the diet, dietary intake appears to be the most significant determinant of the 
fatty acid composition of the milk (151,152).   
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It has been well documented that maternal dietary fat intake is reflected in the fatty 
acid composition of the breast milk (145,151,153-156).  This was evident in a study by 
Harris et al. (154), in which a dose-dependent increase in breast milk DHA was reported in 
women who consumed fish oil supplements for 1 to 4 weeks.  Additionally, Francois et al. 
(151) observed the effects of 6 dietary fats, including menhaden and herring oils, on breast 
milk fatty acids for 6 days following a single fatty meal.  In the menhaden fish oil group, 
DHA appeared within 6 hours after the meal, peaked within 24 hours, and remained 
elevated for up to 3 days.   
 More recently, Francois et al. (157) conducted a study in which lactating women 
were supplemented with 20 grams of flaxseed oil (10.7 g ALA) for 4 weeks.  There was an 
increase in breast milk EPA and DPA, but not DHA.  This was a surprising finding and 
perhaps can be attributed to the strict regulation of DHA synthesis at the level of DPA.  An 
alternative possibility is that the Sprecher pathway does not exist in mammary tissue. 
 Gibson et al. (158) provided the first dose-tissue response curves for dietary DHA 
in human infants fed breast milk.  They showed that the level of DHA in infant plasma and 
erythrocytes is related to the level of DHA in breast milk in a curvilinear fashion.  In their 
study, the curve reached a plateau when DHA was 0.8% of the total fatty acids, thus 
indicating that DHA incorporation is saturable.  Additionally, they reported that the 
increased DHA in blood phospholipids was more closely correlated with the decline in 
total n-6 fatty acids than with the decline in AA al1. 
 In 2 studies that measured the fatty acid composition of breast milk following 
maternal fish oil supplementation, a several-fold increase in breast milk EPA was observed 
in addition to the rise in milk DHA (153,154).  While many studies provide data to support 
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the supplementation of commercial infant formula with n-3 LCPUFA, some evidence 
suggests that EPA may exert detrimental effects in infants.  Lower growth rates have been 
associated with low plasma and RBC concentrations of AA, and it is possible that EPA 
may compete with AA for incorporation into tissue PL and/or the conversion to 
eicosanoids or may inhibit the conversion of LA to AA (159-161).  Supplementation of 
preterm formula with fish oil conferred a transient beneficial effect on visual function, 
negatively affected growth and some indices of neural development (128,162).  This 
potential side effect of n-3 LCPUFA supplementation appears to be offset by the addition 
of AA to formulas already supplemented with DHA (163,164). 
Recommendations for Safety and Adequacy 
Despite the abundance of studies claiming benefits of n-3 LCPUFA 
supplementation in infants, relatively few pinpoint what might be an adequate intake (AI) 
of either ALA or n-3 LCPUFA.  Recent recommendations for infants suggest that at least 
3-4.5% of total energy should be in the form of LA and at least 0.5% in the form of ALA 
to meet minimum EFA requirements (165-170) (Table 1.1).  Intake of LA and other n-6 
fatty acids should be limited to <10% energy and the total PUFA should be limited to 
<15% energy.  When considering the intakes as a percentage of the total fatty acids, LA 
and ALA should account for 10% and 1.5% of the total fatty acids, respectively (171).  
Recommendations for AA and DHA intakes are 0.5% and 0.35% of total fatty acids.  
Additionally, EPA should not be present in amounts greater than 0.10% of the total fatty 
acids.  To date, there is no evidence to support the need for preformed LCPUFA beyond 6 
months of age in infants who were fully breast fed for the first 6 months of life and who 
receive a variety of lipid-rich foods (10).  For adults, the suggested AI for LA is 2.0%  
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Table 1.1  Fatty acid AI* for infant formula/diet 
Fatty acid Percentage of total fatty acids 
LA 10.00 
ALA 1.50 
AA 0.50 
DHA 0.35 
EPA (Upper Limit) <0.10 
* AI = adequate intake.  If sufficient evidence is not available to calculate an estimated 
average requirement, a reference intake called an AI is used instead of a recommended 
dietary allowance.  The AI is a value based on experimentally derived intake levels or 
approximations of healthy people.  The AI for children and adults is expected to meet or 
exceed the amount needed to maintain a defined nutritional state or criterion of adequacy 
in essentially all members of a specific healthy population; LA = linoleic acid; ALA = 
alpha-linolenic acid; AA = arachidonic acid; DHA = docosahexaenoic acid; EPA = 
eicosapentaenoic acid (table modified from reference 7). 
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energy and 1.0% energy for ALA 7).  Pregnant and lactating women require an additional 
300 mg/day of DHA (Table 1.2).   
The benefits of n-3 LCPUFA supplementation are not linearly correlated with the 
dose consumed.  Rather, the maximum benefits achieved reach a plateau, after which, 
additional n-3 LCPUFA consumption ceases to convey additional benefits.  In fact, it 
should be noted that excessive essential fatty acid intakes could have potentially 
deleterious effects at the cellular level (10). 
 One such negative effect is the increased susceptibility to oxidative stress.  The 
high degree of unsaturation observed in DHA, combined with the high aerobic capacity of 
neural tissues sets the stage for potential tissue damage via lipid peroxidation.  The 
products of cellular peroxidation, collectively called reactive oxygen species, include 
superoxide anion, hydrogen peroxide, and hydroxyl radicals (172).  In the last decade or 
so, a number of neurological pathologies, such as ischemic brain damage, 
neurodegenerative disorder, aging and Alzheimer disease, have been attributed to 
excessive oxidation (reviewed in 172). 
The notion that high concentrations of LCPUFA accompanied by excessive oxygen 
consumption and free iron may render the brain more susceptible than other organs to 
oxidative damage has been widely accepted (172).  Moreover, products of lipid 
peroxidation retain their toxic properties for a longer period of time than do free radicals 
(173).  A study by Brand and Yavin (174) showed that DHA added to oligodendroglia-like 
cells caused apoptosis following a genotoxic stress. 
To the contrary, evidence has surfaced that suggests a possible protective role of 
DHA in regard to oxidative stress within neural tissues.  Hossain et al. (175) reported  
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Table 1.2  Fatty acid AI* for adults 
 
 
 
 
 
 
 
 
 
 
 
 
 
* AI = adequate intake.  If sufficient evidence is not available to calculate an estimated 
average requirement, a reference intake called an AI is used instead of a recommended 
dietary allowance.  The AI is a value based on experimentally derived intake levels or 
approximations of healthy people.  The AI for children and adults is expected to meet or 
exceed the amount needed to maintain a defined nutritional state or criterion of adequacy 
in essentially all members of a specific healthy population; LA = linoleic acid; ALA = 
alpha-linolenic acid; AA = arachidonic acid; DHA = docosahexaenoic acid; EPA = 
eicosapentaenoic acid (table modified from reference 7). 
Fatty Acid g/d (2000 kcal diet) % Energy 
LA 4.44 2.0 
Upper Limit 6.67 3.0 
ALA 2.22 1.0 
DHA + EPA 0.65 0.3 
DHA to be at least 0.22 0.1 
EPA to be at least 0.22 0.1 
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lesser quantities of lipid peroxides in areas of rat brain that experienced an increased DHA 
uptake following DHA feeding.  In areas where the level of DHA remained unchanged, no 
decrease in lipid peroxides was observed.   
 Several reports also suggest a role for DHA as a survival factor in photoreceptor 
cells (176-178).  In these studies, DHA was able to rescue photoreceptors from apoptosis, 
the most common pathway of programmed cell death, during the early stages of their 
development in vitro.  Also, this protective effect was specific only to photoreceptor cells, 
as apoptotic events in developing amacrine cells were unaffected by the addition of DHA 
(179).   
 An additional safety concern regarding n-3 PUFA supplementation is the possible 
interference with n-6 eicosanoid synthesis.  Since n-3 and n-6 eicosanoids are synthesized 
by the same enzymes, an increase in n-3 PUFA, particularly EPA, could negatively shift 
the physiological balance between n-6 and n-3 derived prostaglandins and thromboxanes.  
One consequence of such a shift is an increase in bleeding time (increased time to clotting).  
While a decreased risk of spontaneous clotting is a positive effect of n-3 supplementation, 
there is some concern that extremely high doses may result in abnormally long bleeding 
times.  Studies in Inuit Eskimos, a population with a high marine fish oil intake, indeed 
report an increase in bleeding time as a result of the imbalance between pro- and anti-
aggregatory eicosanoids (180).  Similar studies of bleeding times in fish oil-supplemented 
pregnant women have yielded mixed results.  One study reported a slight, but significant 
increase in blood loss at delivery, whereas a larger study found no difference between 
supplemented and non-supplemented mothers (181,182). 
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Earlier in this chapter, it was menti1d that some studies have reported an adverse 
effect of high EPA intake on infant growth.  It is possible that the increased levels of EPA 
suppress conversion of AA to prostaglandin E2, which has been shown to stimulate cell 
proliferation in vitro (183-185).  This evidence underscores the importance of limiting an 
infant’s EPA consumption to <0.1% of total fatty acids. 
Obviously the potential adverse side effects of unusually high concentrations of 
LCPUFA within biological systems and membranes remain unclear.  Until the possible 
long-term effects of n-3 LCPUFA supplementation are more thoroughly identified, it is 
advisable to avoid excess intakes.   
Canine Neurologic Development 
 Only limited information regarding canine DHA metabolism is available, but studies 
to date suggest that DHA is required in canine nervous system and neonatal development.  
Anderson, et al. demonstrated that canine retina is capable of synthesizing DHA from its 
22-carbon precursor, DPA, that DHA is highly conserved in the retina, and that it has a 
role in neurological function in this tissue (83,186).  Alternatively, our laboratory has 
reported the accumulation of DPA, but not DHA, in plasma PL when ALA is fed (187).  
Although accumulation of DHA was not observed in the plasma fraction of adult dogs, the 
possibility exists that the noted increase in DPA is an important regulatory step prior to 
nervous tissue uptake and subsequent retinal DHA synthesis.  This notion is consistent 
with Alvarez, et al. (186) who found that canine nervous tissue could convert DPA to 
DHA.  Therefore, it is likely that canine retina, and presumably other nervous tissues, 
synthesize and utilize DHA in a manner similar to other mammalian species and that 
plasma DPA provides a likely substrate for such synthesis.  It also is possible that a dietary 
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source of DHA, whether as the 18-carbon precursor or as a preformed long-chain fatty 
acid, may be necessary during gestation and suckling for normal neural development in 
dogs.       
 ALA may be sufficient as a dietary precursor for the synthesis of requisite amounts of 
DHA during pre- and postnatal development.  However, what quantity of ALA may be 
needed to optimize neural development in companion animals currently is not known.  
Additionally, because both n-6 and n-3 fatty acids compete for the same enzyme systems, 
it also is unclear what role the dietary LA/ALA ratio has on subsequent n-3 synthesis.  An 
alternate approach to using dietary ALA as a DHA precursor would be to supply pre-
formed amounts of DHA in canine gestational and lactational diets.  Regardless of the 
source of DHA, data on the competitive metabolism of either the 18-carbon or the 20/22-
carbon n-3 and n-6 fatty acids and their effects on neurological tissue will be needed in 
order to better understand what dietary amounts of PUFA are necessary.   
 In theory, the DHA requirement of neural tissues may be met in one of 4 possible 
ways:  desaturation and elongation of ALA within the brain and retina; uptake of DPA 
following hepatic conversion from ALA and further conversion within the brain and retinal 
tissue to DHA; uptake of circulating DHA previously synthesized in tissues such as liver; 
and uptake of DHA directly from dietary sources.  The studies presented here provide 
important new information as to which of these possibilities most likely exists in dogs.   
Canine Milk Composition 
Many of the earlier studies of canine milk composition were limited to 
macronutrient analysis, i.e. carbohydrate, protein and total fat content, and fatty acid 
analyses were not performed.  To our knowledge only three published reports exist 
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regarding the fatty acid composition of canine milk (188-190).  Iverson, et al. (188) 
observed no PUFA with chain length greater than 20 carbons (predominately AA), 
although they routinely identified longer chain fatty acids, including n-3 PUFA, both in 
analytical standards and in marine oil.  This finding is in contrast to a later study by Lepine 
in which small amounts of DHA were found in canine milk (190).   
 Our laboratory recently conducted a preliminary study on canine milk composition 
(189).  In this study, females were fed Hill’s Science Diet® Canine Growth® formula prior 
to breeding, during gestation and throughout lactation.  Because different batches of this 
commercial diet were fed over time, the n-3 fatty acid content could only be estimated 
based on the analysis of a single batch.  Nonetheless, it was determined that the n-3 content 
of the diet was low.  Values on a dry matter basis were as follows:  0.3% ALA; 0.0% EPA; 
0.03% DPA (n-3); and 0.01% DHA.  The n-6 fatty acids in the diet were:  4.6% LA and 
0.1% AA.  Similarly, milk from the dogs fed these diets contained low amounts of n-3 
fatty acids and high amounts of n-6 fatty acids.  Perhaps most striking was the finding that, 
compared with human breast milk of various populations, canine milk contained about 
seven times less DHA and about 2 times more AA.  LA content of canine milk was slightly 
higher than human milk, and ALA was about the same as human milk.  These preliminary 
observations are of special interest because canine neurological tissues such as retina and 
brain contain the same high proportions of long-chain n-3 and n-6 PUFAs as do the same 
tissues in humans.  Therefore, the emergent question is whether canine milk containing 
low DHA and high AA is the most appropriate to assure proper neural development for 
suckling neonates.  One objective of this research was to address this question.   
 40
Canine Vision 
 Although details on the visual anatomy and physiology of canines have yet to be 
fully established, a few studies have provided data which allow for the comparison of 
human and canine retina.  The visual system of the dog has evolved for survival in an 
arrhythmic photic existence rather than being adapted strictly for diurnal or nocturnal 
vision, as are humans (191).  That is to say, canine vision can adapt to enhance visual 
performance in dim light while retaining the ability to function under bright light 
conditions. 
 In both dogs and humans, the rod photoreceptors are employed for vision in dim 
light.  Whereas in humans the central 25° of retina consists primarily of cones, in canids 
this region predominantly contains rod photoreceptors (192).  Furthermore, the rhodopsin 
molecule varies slightly between both species.  Canine rhodopsin has a peak sensitivity 
between 506 and 510 nm, which is crucial to a dog’s ability to function in dim light.  
Moreover, the regeneration of canine rhodopsin following extensive bright light exposure 
can take well over an hour (192-194).  Human rhodopsin, on the other hand, exhibits 
maximal sensitivity at 496 nm and regenerates much more quickly following photoreceptor 
bleaching (195).   
 Flicker fusion, the point at which rapidly flickering light appears to fuse into 
constant illuminated light, has provided an inroad toward the understanding of the 
functional characteristics of the canine photoreceptors (195).  Electroretinographic data 
from anesthetized dogs suggest that canine rods can detect flickering up to a maximum of 
20 Hz, which is similar to the maximum reported in human rods (196-199).  However, 
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maximal flicker frequency of the cone photoreceptors is somewhat higher in dogs than in 
humans (196,197,200).   
Visual Acuity   
Although visual acuity is not of primary interest in this research, it has been 
employed in numerous studies as a measure of neural development in primate infants.  
Visual acuity refers to the ability to see the details of an object separately and unblurred 
(201).  It is this ability that allows the visual system of the dog to function well in low light 
situations.  Odom and colleagues suggested that canine visual acuity is limited by the 
retina and not by postretinal neural processing or the optical properties of the eye itself 
(202). 
 Generally, enhanced nocturnal vision necessarily requires that a large number of 
rod photoreceptors synaptically converge upon a single ganglion cell (195).  Such a 
structural arrangement usually results in decreased visual acuity.  To the contrary, retinas 
with superior resolving power have a high ratio of ganglion cells to photoreceptors, a large 
number of ganglion cells and optic nerve fibers, and a high density of photoreceptors 
(191).  The visual acuity of dogs is believed to be intermediate to that of felines and 
primates (202).  Reportedly, human optic nerve contains 1.2 x 106 fibers compared to 
167,000 and between 116,000 and 165,000 respectively, in canine and feline optic nerves 
(203-207).  Although the ratio of photoreceptors to ganglion cells has not been determined 
in dogs, it is believed to be similar to that reported in cats—4 cones/ganglion cell—which 
compares with a ratio of one cone/ganglion cell in the primate fovea (195,208).   
 Instead of a fovea, as is found in primate retina, the area of highest visual acuity in 
dogs is the visual streak, which is an ovate region located superior and temporal to the 
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optic nerve (209-211).  Work by Kemp and Jacobson (192) provided detailed maps of 
photopigment concentrations that showed the visual streak to contain high concentrations 
of rhodopsin.  Additionally, the binocular vision of dogs most likely is enhanced by the 
temporal region of the visual streak (209,210).  Finally, it should be noted that retinal 
ganglion cell topography, and thus visual acuity, can vary greatly amongst breeds (209). 
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CHAPTER II 
MATERIALS AND METHODS 
Experimental Design 
Animals 
Dogs for this study were approved for use by the Texas A&M University 
Laboratory Animal Care Committee (ULACC AUP #2001-110).  Animals were housed 
at the veterinary small animal clinic during the study and were returned to the 
Laboratory Animal Research Resources (LARR) facility after they had completed their 
role in the study. Prior to entering the study, complete blood counts were obtained to 
ensure overall health of the animals.  All dogs used in the study appeared to be clinically 
and physiologically normal. 
Twelve clinically normal, sexually intact adult female hound/Labrador retriever 
crossbred dogs, ages 2 to 4 yr old, and their subsequent puppy litters were used in the 
study.  The puppies were evaluated from birth until 12 wk of age.  The females were 
bred to the same sire, a yellow Labrador retriever, via artificial insemination.  The body 
weights of the mothers and the puppies were recorded throughout the study and are 
included in the Appendix A, Tables A-I and A-II.     
 Before entering the study, all animals were housed at the LARR facility where 
they were monitored for signs of proestrus.  Upon the onset of proestrus, the dogs were 
brought to the Texas A&M University Veterinary Clinic for confirmation of proestrus 
and for subsequent artificial insemination.  At this time, each dog was randomly 
assigned to one of the four experimental diets, and an EDTA blood sample was taken.  
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This pre-experimental diet sample, designated as d –3, was also used as a basis for 
comparison of plasma fatty acid composition between the maintenance and experimental 
diets.  Each animal was inseminated 3 to 5 times, depending upon the individual stage of 
proestrus at the time of breeding, to increase the likelihood of conception.  The third 
insemination day was marked as d 0 of gestation for the purpose of this study.   
Diets and Feeding 
The diets for the study were manufactured by Nestlé-Purina Pet Care® (St. 
Louis, MO) and were complete and balanced for all canine life stages.  All diets 
contained sufficient amounts of LA ranging from 1.8-3.5% dry matter (DM), and 
differed in their fatty acid compositions.  Each diet consisted of approximately 15% total 
fat and contained one of the following as its primary fat source:  beef tallow, linseed oil, 
“low” amounts of Menhaden fish oil or “high” amounts of Menhaden fish oil.  Each diet 
was designed to have a unique ratio of its ALA to n-3 LCPUFA content.  Based on these 
relative amounts, the diets were designated as low ALA/low n-3 LCPUFA (Lo/Lo, 
tallow); high ALA/low n-3 LCPUFA (Hi/Lo, linseed oil); low ALA/moderate n-3 
LCPUFA (Lo/Mod, low Menhaden fish oil); and low/high (Lo/Hi, high Menhaden fish 
oil).  All other components of the diets, including total protein, nitrogen-free extract, 
vitamins and minerals, were identical.  The nutrient compositions, list of ingredients, and 
the fatty acid compositions of each diet can be found in the appendix (Tables B-I to B-
III). 
Dogs were fed their respective diets at the time of first insemination and was 
maintained on that diet throughout their subsequent gestation, parturition, and lactation 
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periods.  Sufficient quantities of the diets were fed to maintain weight gain during the 
latter stages of gestation by adjusting the amounts fed as necessary.  Body weights were 
monitored weekly in order to determine adequate quantities of food.  At 21 d 
postpartum, a gruel consisting of the mothers’ respective diets and water was offered to 
the puppies three times a day, in addition to suckling.  Gradually, the time the puppies 
spent suckling was decreased until they were completely weaned by d 28.  Upon 
weaning, puppies were continued on the same diets as their mothers until 12 wk of age.  
The puppies were weighed daily until 6 wk of age and every other day thereafter to 
ensure proper growth and development.  If any failure-to-thrive issues arose, the puppy 
was removed from the study and supplemented to ensure proper nutrition.  Generally 
this occurred only when litter size was large; small puppies were the most likely to be 
removed. 
Veterinary student workers fed and provided clean water for the dogs daily.  The 
mothers were fed once a day during early gestation, up to three times a day during late 
gestation, and twice a day during lactation.  The puppies were fed their respective dry 
diet and water three times a day after weaning.  Prior to this study, the adult dogs had 
been fed Hill’s Science Diet® Canine Maintenance® (Topeka, KS) diet twice a day. 
At 12 wk of age, retinal development of the puppies was assessed via 
electroretinography (ERG).  The ERG procedure is outlined later in this chapter.   The 
completion of the ERGs marked the end of the study, at which time suitable homes were 
found for the puppies. 
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Blood Samples 
Blood samples were collected from mothers and puppies via venipuncture and 
transferred into tubes containing 7.5% EDTA. 
Blood was collected from the mothers prior to artificial insemination (d –3) and 
at d 3, 7, 14, 28, 42 and 56 during gestation and d 10 and 28 during lactation.  Food was 
withheld from each dog overnight prior to taking the blood samples.  Seven milliliters of 
blood was collected on all days except for d 14 and 42, when 14 mL was taken.   
Blood was taken from the puppies at 4, 10, 16, 28, 70 and 84 d of age.  The 
puppies were removed from their mothers for 3 h prior to blood collection on d 4, 10, 16 
and 28, and food was withheld overnight on d 70 and 84.  Two milliliters of blood was 
taken each sample day through d 16. On d 28, 4 mL were collected, and on d 70 and 84, 
7 mL were obtained.  
Plasma from each sample and red blood cells (RBC) from selected sample days 
were harvested immediately following collection.  The samples were centrifuged for 15 
min at 2800 rpm in a Centra-7 centrifuge (International Equipment Company, Needham, 
MA).  Plasma was separated from the RBC for subsequent lipid extraction.  Red blood 
cells, collected from adult dogs on d 3, 7, 42 and 56 of gestation, d 10 and 28 of lactation 
and from puppies on d 4, 28, 70 and 84, were diluted with isotonic saline (0.9% NaCl, 
1:1 (v/v) ratio).  Both the plasma and RBC fractions were extracted immediately or were 
stored at -20ºC until the time of extraction.  Erythrocyte samples were stored no longer 
than 2 wk and plasma no longer than 4 wk prior to analysis. 
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Lipid extraction.  Plasma, erythrocyte, and milk samples were subjected to lipid 
extraction via a modified Folch procedure (212).  Five hundred microliters of each adult 
plasma, adult RBC and neonate RBC sample and 300 µL of each milk and neonate 
plasma sample was transferred to a 12-mL teflon-lined screw top glass test tube.  To 
each sample was added 9.0 mL of chloroform:methanol (2:1, v/v) with 0.2% glacial 
acetic acid.  The samples were shaken in a tube shaker (Shaker-in-the-Round Model S-
500; Kraft Apparatus, Inc., Mineola, NY) for 20 min at room temperature (27 °C).  After 
shaking, 2.0 mL of distilled water was added to each sample.  Samples were then shaken 
for an additional 10 min and were centrifuged for 15 min at 2800 rpm.  The infranates 
were transferred to clean test tubes and washed with 5.0 mL of 
chloroform:methanol:water (3:48:47, v/v/v).  The samples were shaken again for 10 min 
and spun for 15 min.  The infranates were transferred, via glass wool filtration, to clean 
tubes.  Each sample was purged with nitrogen gas and stored in tightly sealed screw-
capped glass tubes at -20°C until further analysis as described below. 
Thin layer chromatography.  Plasma lipid subclasses were separated using thin 
layer chromatography (TLC).  Lipid samples were evaporated under nitrogen gas and 
resuspended in 300 µL chloroform, 150 µL of which was applied to a 20x20 cm, 250-
µm thickness silica gel G coated plate (Fisher Scientific, Suwanee, GA).  Prior to use, 
plates were washed in chloroform:methanol (2:1, v/v), air-dried briefly, and then 
activated in a 110°C oven (National Appliance Company Model 5510, Portland, OR) for 
1 h.  The plates were stored in a sealed plate box until needed, but were stored no longer 
than 1 wk.  The lipid extracts were developed in a filter paper (Whatman International, 
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Ltd., Maidstone, England) lined, covered glass tank.  A hexane:ether:acetic acid solution 
(80:20:1, v/v/v) was used as the mobile phase.  The tank was equilibrated for no less 
than 1 h prior to developing a plate with samples.  Plates were loaded with 4-5 samples, 
and at least one plate contained a standard lipid mixture (TLC Standard #18-5-A; Nu-
Check Prep, Elysian, MN).  Plates were developed in the tank until the solvent front 
reached 1-2 cm from the top of the plate.  The plate was removed, dried briefly in a fume 
hood, and lipid subfractions were visualized in an iodine vapor chamber.  Phospholipid 
subfractions were removed by scraping prior to visualization in the iodine tank, but the 
TG and CE subfractions were marked after being subjected to iodine vapor.  The iodine 
was allowed to dissipate under nitrogen gas and the subfractions then were scraped into 
a clean teflon-lined screw top test tube to which was added 2.0 mL of a 4% sulfuric acid 
in methanol solution.  Samples were transmethylated directly, as described below, or 
were purged with nitrogen gas and stored at -20°C until the time of methylation.   
Red blood cell phospholipid separation.   Red blood cell extracts were 
evaporated under nitrogen gas and resuspended in 150 µL chloroform, all of which was 
applied to an activated TLC plate. The plates were developed in the same manner and 
solvent system as the plasma samples.  Red blood cell total PL were scraped without 
visualization in iodine vapor; no other lipid subclasses were collected.  The total PL 
subsequently were prepared for transmethylation as previously described.   
Methylation of lipid subfraction fatty acids.  Previously separated lipid 
subfractions in 4% sulfuric acid in methanol were heated in a 90°C water bath (Thelco 
182, Model 66570; GCA Precision Scientific, Chicago, IL) for 50 min.  Samples were 
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removed from the water bath and allowed to cool for 5 min.  Three milliliters of hexane 
was then added to each tube, and the tubes were mixed for 30 seconds each on a Vortex-
Genie Model K-550-G (Scientific Industries, Inc., Bohemia, NY).  All tubes were 
centrifuged for 15 min at 2800 rpm.  The supernates, which contained the fatty acid 
methyl esters (FAMEs), were transferred to clean test tubes, purged with nitrogen gas, 
and stored at -20°C for subsequent analysis by capillary gas chromatography.   
Gas chromatography.  The transmethylated samples were evaporated to dryness 
under nitrogen gas, and the FAMEs were resuspended in a known volume of hexane.  
Two microliters of each sample was injected onto the capillary column (FAMEWAX 
Crossbond®-PEG; Restek, Bellefonte, PA) of a Hewlett Packard Series II 5890 Gas 
Chromatograph.  Helium was used as the carrier gas, and the oven temperature was 
ramped from 170°C to 220°C over a period of 90 min.  In all runs, 24:1n-9 is the last 
possible identifiable fatty acid peak in this system.  Hewlett Packard HP ChemStation 
software package was used to generate results from the analyses.  Authentic fatty acid 
methyl ester standards (Nu-Check-Prep, Elysian, MN) were used to identify the 
individual fatty acid peaks by comparing retention times.   
Electroretinography 
Electroretinograms were recorded using the Cornell ERG System (Cornell 
University, Ithaca, NY), a custom-built, computer-based ERG acquisition system 
(Windows-based software; Microsoft, Redmond, WA) was acquired from colleagues at 
the Cornell University veterinary hospital (Dr. Ellis Loew). 
On the day ERGs were performed, 12-wk-old puppies had been dark adapted for 
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2 h prior to measurement.  Before the procedure was begun, 0.04 mg/kg atropine sulfate 
(Sparhawk Laboratories, Inc., Lenexa, KS) was administered subcutaneously as a 
preanesthetic.  This was followed by a subcutaneous injection of 20 mg/kg ketamine 
hydrochloride (Ketaset®; Fort Dodge Animal Health, Overland Park, KS) and 2.0 mg/kg 
xylazine (Vedo, Inc., St. Joseph, MO).  When the puppies were sufficiently sedated, they 
were positioned in lateral recumbancy on the examination table, and subdermal 
platinum-iridium needle electrodes were placed on the muzzle (indifferent) and in an ear 
flap (ground).  The eye to be tested was then exposed using a lens speculum inserted 
underneath the lids and the nictitating membrane.  Local anesthesia was achieved using a 
of 0.5% solution of proparacaine hydrochloride (Ophthetic®; Allergan America, 
Hormigueros, Puerto Rico) applied to the cornea, and pupillary mydriasis was induced 
by the addition of one drop of 1.0% tropicamide (Mydriacyl®; Alcon Laboratories, Ft. 
Worth, TX) before placing the active contact lens electrode (ERG-Jet; LKC Technology, 
Gaithersburg, MD) on the eye. 
Each eye was tested separately using a series of square-wave flash stimuli 50 
msec in duration, with an inter-flash interval of 5 s, from a white-light emitting diode 
(LED) placed approximately 1 cm from the cornea.  The ERGs were obtained at 10 
increasing 0.5 log unit intensity steps up to b-wave saturation.  The highest intensity 
setting has been found to saturate the rod response in canines (213).  The parameters 
used to assess ERG characteristics were a- and b-wave amplitudes, a- and b-wave 
implicit times.  A typical ERG series obtained with the equipment used in this study can 
be found in Figure 2.1. 
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Figure 2.1  Typical ERG trace obtained in this experiment.  This series shows 
the rod photoreceptor response at 10 increasing 0.5 log unit intensity steps up to b-wave 
saturation.  The highest intensity setting has been shown to saturate the rod response in 
canines (Loew, personal communications). 
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Following the completion of the ERGs, veterinary technicians monitored the 
puppies until they fully recovered from anesthesia.  The animals then were removed 
from the study and gradually were weaned from the experimental diet to Hill’s Science 
Diet® Canine Growth® formula.   
Statistical Analyses 
The effect of diet and time on the individual plasma phospholipid fatty acid data 
from adult dogs was evaluated using a multivariate model that accounted for the random 
variance of dog.  Repeated measures analysis of variance (ANOVA) with multiple 
comparisons where appropriate for main effects of diet, time and diet*time interactions 
were performed at p < 0.05 (Statistix 7.0; Analytical Software, Tallahassee, FL).  Where 
there was a significant interaction of group and time, contrasts were made for each 
plasma phospholipid fatty acid using Bonferroni’s test to determine where the difference 
occurred.  An experiment-wide type I error of 0.05 was maintained.  Milk fatty acid data 
were similarly analyzed via repeated measures ANOVA with Bonferroni multiple 
comparisons.  One-way ANOVA was performed on the adult plasma phospholipid data 
comparing gestation d 56 and lactation d 28 to investigate statistically significant 
differences of plasma phospholipid fatty acids at the end of gestation with the end of 
lactation.  
Puppy plasma phospholipid fatty acid data were analyzed by repeated measures 
ANOVA using litter as experimental unit with Bonferroni’s multiple comparisons of 
main effects of diet, time and time*diet interactions at p < 0.05.  Puppy plasma PL data 
from d 28 and 84 were evaluated via one-way ANOVA as were the ERG parameters.  
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When ANOVA was significant, pair-wise comparisons were made using Bonferroni’s 
test at p < 0.05. 
 
 54
CHAPTER III 
EFFECTS OF DIETARY ALA AND N-3 LCPUFA ON MATERNAL 
PLASMA PHOSPHOLIPIDS DURING GESTATION IN CANINES 
Introduction 
 Both the n-3 and n-6 classes of long-chain polyunsaturated fatty acids are important 
in perinatal growth and development.   Brain and retinal functions depend on the n-3 
polyunsaturate docosahexaenoic acid (22:6 n-3, DHA) not only during gestational 
development, but during postnatal life as well.  Maximal brain growth begins in the third 
trimester of gestation and continues throughout the first few months of neonatal life (42-
44).  During this crucial period, there is a select accumulation of both arachidonic acid 
(20:4 n-6, AA) and DHA in brain and retina which occurs ten times faster than 
incorporation of their respective precursors, linoleic acid (18:2 n-6, LA) and alpha-
linolenic acid (18:3 n-3, ALA) via chain elongation (47, 48).   In accordance with this 
knowledge, several authors have demonstrated that plasma DHA is the preferred substrate 
for retinal uptake in early developmental stages when the demand for DHA is greatest (78, 
81, 83).   
Canine Neurologic Development 
 The tenacious conservation of DHA within the retina suggests it has a role in 
neurologic function (83).  Anderson et al. (58) demonstrated that canine retina is capable 
of synthesizing DHA from its 22-carbon precursor, docosapentaenoic acid (22:5 n-3, 
DPA).   Bauer et al. (187) reported the accumulation of DPA, but not DHA, in canine 
plasma phospholipids when the precursor ALA is fed.  It, therefore, is likely that canine 
retina, and presumably other nervous tissues, synthesize and utilize DHA in a manner 
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similar to other mammalian species and that plasma DPA provides a likely substrate for 
such synthesis.  Thus, a dietary source of pre-formed DHA or one of its precursors may be 
necessary during gestation and suckling for normal neural development in dogs.   
 It is possible that ALA may be sufficient as a dietary precursor for the synthesis of 
requisite amounts of DHA during pre- and postnatal development.  However, what 
quantity of ALA may be needed to optimize neural development in companion animals 
currently is not known.  Additionally, because both n-6 and n-3 fatty acids compete for the 
same enzyme systems, it also is unclear what relative amounts may be needed.    
Materials and Methods 
 An existing breeding colony of dogs provided bred hound/Labrador retriever dogs 
and their puppies for this study.  The colony contains a kindred of dogs with hereditary 
nephritis (214) but all dogs used in this study were clinically healthy.  Twelve dogs (three 
each per diet group) were fed one of four complete and balanced, extruded-type diets from 
the time of insemination and throughout gestation, parturition, and lactation.  Sufficient 
quantities of the diets were fed to maintain weight gain in the latter stages of gestation by 
adjusting the amount fed as necessary.  The diets were similarly formulated, but differed in 
their fatty acid composition and were sufficient in linoleic acid (Appendix B, Table B-I).  
They contained approximately 15% total fat using either beef tallow, linseed oil, or higher 
and lower amounts of menhaden fish oil as primary fat source (Nestle-Purina PetCare, St. 
Louis).  Using these dietary fat sources, diets were formulated using typical pet food 
ingredients to contain adequate linoleic acid ranging from 1.8 to 3.5 % dry matter (DM) 
and were designated based on their ALA/n-3 LCPUFA contents as follows:  Lo/Lo, Lo/ 
 56
Mod, Lo/Hi, and Hi/Lo.  All other dietary ingredients including total protein, nitrogen-free 
extract, vitamins, and minerals were identical in all diets (Appendix B, Table B-II).  
EDTA blood samples were collected on d 3, 7, 14, 28, 42, and 56 post breeding.  
As described previously, plasma total lipids were extracted using chloroform:methanol 
(2:1, v/v) and subsequently separated into subclasses via thin-layer chromatography.  Fatty 
acid methyl esters were prepared, using the total phospholipid subfraction (plasma PL), 
and fatty acid profiles were determined via gas chromatography (187).   Statistical analyses 
were performed by repeated measures ANOVA with Bonferroni comparisons performed at 
p < 0.05 for plasma PL fatty acids.  One-way ANOVA was also performed on plasma PL 
data from day 56 of gestation to compare statistically significant differences between the 
beginning and end of gestation. 
Results 
 Initially, all dogs had similar plasma phospholipid (PL) fatty acid profiles before 
being placed on their respective experimental diets; no significant pre-experimental diet 
differences in any plasma PL fatty acid existed among groups.  No widespread time effects 
or time*diet interactions during gestation were detected at p < 0.05.   
 A dose response for LA in plasma PL fatty acid profiles was apparent by d 14, and 
persisted through d 56, of gestation (Figure 3.1a).  The Hi/Lo diet contained 3.5% LA on a 
DM basis, which was more than twice that contained in the Lo/Hi diet.  Consequently, the 
plasma PL LA of both these groups mirrored these dietary differences.  At the end of 
gestation, plasma PL LA was 17.9 + 2.6% S.D. in the Hi/Lo group compared with 8.2 + 
0.6% S.D. in the Lo/Hi group.  Plasma PL LA concentrations in the Lo/Lo and Lo/Mod 
groups were intermediate to these values.  Surprisingly, plasma PL AA remained  
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 Figure 3.1  Mean + S.D.  plasma PL n-6 PUFA during gestation in dogs fed the 
experimental diets.  Pre-experimental diet fatty acid profiles, shown as d –3, were not 
significantly different among dogs at p < 0.05 (n = 3 per group).  Dietary LA (a) and AA 
(b) contents are indicated on a % DM basis in each respective figure legend.  Plasma AA 
was not significantly altered from pre-diet levels in any group at p < 0.05.   
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relatively constant within all diet groups throughout gestation (Figure 3.1b).  Although the 
Hi/Lo diet contained a fairly high amount of the precursor LA (3.5% DM), plasma PL 
arachidonate in this diet group, as in all others, was not significantly different from pre-
study values, nor was it different from the other groups.   
 Noticeable differences in the n-3 fatty acids were observed as well.  In the Hi/Lo 
(high ALA) group, plasma PL ALA was significantly elevated above all other groups for 
the entirety of gestation (Figure 3.2a).  Plasma PL ALA increased modestly by d 3 of 
gestation and was significantly higher than pre-diet levels by d 14, whereas plasma PL 
ALA remained unchanged in the other diet groups.  This spike in plasma PL ALA 
occurred concomitantly with a sharp rise in EPA (Figure 3.2b) and DPA (Figure 3.3a) by d 
14.  Interestingly, plasma PL ALA and EPA values were roughly halved at d 28, but DPA 
remained steady.   
 The Lo/Lo and Hi/Lo diets contained equivalent amounts of derived n-3 LCPUFA, 
yet plasma EPA in the Hi/Lo group was significantly different from plasma in the Lo/Lo 
group.  Curiously though, the plasma PL concentration of DHA (Figure 3.3b) was similar 
between both groups.  Although the Lo/Hi diet contained derived LCPUFA in 
concentrations two times those of the Lo/Mod diet and roughly 20 times those in the Hi/Lo 
diet, the differences in plasma PL concentrations of the LCPUFA did not parallel these 
dietary differences.  Mean plasma PL EPA in the Lo/Hi group during gestation was 3.5 + 
2.0% S.D. compared to 2.3 + 1.8% S.D. and 2.6 + 2.3% S.D., in the Lo/Mod and Hi/Lo 
diets, respectively.  None of these values were significantly different from each other.  
Plasma PL DHA became markedly elevated by d 3 in the Lo/Hi group while a less 
exaggerated increase occurred in the Lo/Mod group.  The rise in plasma PL DHA in  
 59
Day of Gestation
(a)
0 7 14 21 28 35 42 49 56
Pl
as
m
a 
PL
 A
LA
 C
on
te
nt
 (R
el
at
iv
e 
%
)
-1
0
1
2
3
4
5 0.14% ALA (Lo/Lo)0.29% ALA (Lo/Mod)
0.20% ALA (Lo/Hi)
6.82% ALA (Hi/Lo)
 
Day of Gestation
(b)
0 7 14 21 28 35 42 49 56
Pl
as
m
a 
PL
 E
PA
 C
on
te
nt
 (R
el
at
iv
e 
%
)
0
2
4
6
8
0.02% EPA (Lo/Lo)
0.19% EPA (Lo/Mod)
0.5% EPA (Lo/Hi)
0.02% EPA (Hi/Lo)
 
Figure 3.2  Mean + S.D. plasma PL ALA (a) and EPA (b) during gestation in dogs 
fed experimental diets.  Pre-experimental diet fatty acid profiles, shown as d –3, were not 
significantly different among dogs at p < 0.05 (n = 3 per group).  Dietary ALA and EPA 
contents are indicated on a % DM basis in each respective figure legend.     
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Figure 3.3  Mean + S.D. plasma PL DPA (a), and DHA (b) during gestation in 
dogs fed the experimental diets.  Pre-experimental diet fatty acid profiles, shown as d –3, 
were not significantly different among dogs at p < 0.05 (n = 3 per group).  
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these two groups persisted throughout gestation.  Mean plasma PL DHA values in the 
moderate and high fish-oil diet groups were significantly different from both the Lo/Lo and 
Hi/Lo groups, but they were not significantly different from each other. Because 
differences over time did not exist during gestation, data from all sample days, excluding d 
–3, were pooled.  Mean plasma n-6 and n-3 PUFA contents are indicated in Figures 3.4a 
and 3.4b, respectively.  
 The highest plasma PL value of 22:5 n-3, DPA, was observed in the Hi/Lo group 
rather than in either of the fish oil-diet groups.  Phospholipid DPA in the Hi/Lo group 
remained elevated well above all other diet groups through d 28 (Figure 3.3a), after which 
the plasma concentration declined slightly but was still greater than the other three groups.  
These differences, however, did not attain statistical significance. 
 Regression analysis of the n-3 PUFA revealed that plasma PL ALA and PL DHA 
content were highly correlated with dietary concentrations of the respective fatty acids 
(Figure 3.5).  Correlation coefficients (r2) for these analyses were 0.997 and 0.999, 
respectively.  Similarly, plasma PL LA content was closely related to dietary LA content 
(r2 = 0.841, regression not shown).  However, this relationship did not hold for AA and the 
other n-3 PUFA, whose correlation coefficients were less than 0.5.  Smaller values of r2 
indicate that a factor or factors other than dietary intake of the given fatty acids contributed 
to the variation in their plasma concentrations, and are consistent with the data of Bauer et 
al. from which predictive equations based on saturation kinetics have been developed 
(214).  In the case of EPA and DPA, the elongation and desaturation of ALA can account 
for the curvilinear relationship between dietary and plasma amounts of these fatty acids. 
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Figure 3.4  Mean + S.D. plasma PL content of LA and AA (a) and major n-3 
PUFA (b) during gestation.  The diets are designated Lo/Lo, Lo/Mod, Lo/Hi, and Hi/Lo 
based on their ALA/n-3 LCPUFA contents.  Letters not in common for individual fatty 
acids are significantly different with respect to diet at p < 0.05. 
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Figure 3.5  Linear regression of plasma ALA vs. dietary ALA (a) and plasma DHA 
vs. dietary DHA (b).  Plasma concentrations of these fatty acids, as well as LA (not 
shown), are strongly correlated with their concentrations in the diet, as indicated by the 
high r2 values.  
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Finally, a general decline in most PUFA occurred across all experimental groups 
around d 28 of gestation and then slowly increased by d 56.  This trend may reflect the 
placental transfer of fatty acids in gestating canids. 
Discussion 
Dietary LA varied more than two-fold in the experimental diets, which resulted in a 
dose response of LA in the plasma PL.  By contrast, however, plasma PL AA amounts 
were fairly steady across all experimental groups throughout gestation.  According to 
predictive equations devised by Bauer et al. (215), tissue LA and AA become saturated at 
low concentrations of dietary LA.  Based on those equations, dietary LA in all groups in 
this study was adequate to induce tissue saturation.  Moreover, both dietary LA and ALA 
in the Hi/Lo group were unusually high (3.5% DM and 6.8% DM, respectively).  
Therefore it is also likely that ALA somewhat limited the elongation of LA via 
competition for ∆6 desaturase.  Studies of ∆6 desaturase enzyme kinetics indeed indicate 
that LA and ALA compete for access to the enzyme’s active site (216).  These topics are 
discussed in further detail in Chapter IV of this dissertation.  
The observation that the Hi/Lo group had the highest plasma PL concentration of 
DPA despite the very low dietary DPA content is of particular interest.  Undoubtedly, the 
Hi/Lo group actively converted ALA to its longer-chain derivatives, EPA and DPA.  
However, further conversion to DHA was minimal in this group when plasma PL fractions 
are considered.  Accumulation of DPA did not occur in the fish oil groups even though 
derived DPA was present in amounts many times higher than in the high ALA diet.  The 
lack of significant plasma accrual of DPA in the fish oil-diet groups suggests that DPA is 
probably a rather transient intermediate between EPA retroconversion and DHA synthesis.   
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The fact that DPA accumulation occurred in the Hi/Lo group indicates that, 
although conversion of ALA occurs, its final conversion to DHA is limited at some 
regulatory point.  This finding is not unique to gestating dogs; Bauer et al. (187) reported 
similar results when non-gestating dogs were fed high-ALA (10% total fatty acids) diets.  
In that study, the accumulation of DPA, but not DHA, was observed in plasma PL.  Innis et 
al. (12) demonstrated in rat brain astrocytes that synthesis of DHA was limited at the 
elongation and subsequent desaturation of DPA.  Furthermore, Sprecher (217) reported 
that the rate-limiting step in the final conversion to DHA occurs at the ∆6 desaturase.  
However, the substrate for this reaction is 24:5 n-3, not DPA.  Thus, another point of 
limitation must exist upstream from this ∆6 desaturase step.  In general, the elongation 
reactions are believed to be rapid and, thus, not rate-limiting.  Therefore, the possibility 
exists that the limitation is in the mechanism by which DPA gains entry either into the 
peroxisomes or into the cells themselves.  Although the details are unknown, this process 
is likely carrier-mediated and saturable.  Consequently, and regardless of the abundance of 
DPA, once the transport system is saturated, DPA will begin to accumulate in either the 
cytoplasm or the plasma.    The data presented here further emphasize the importance of 
dietary derived n-3 LCPUFA, rather than ALA, for gestating mothers.  Further studies 
must be done to assess the exact mechanism of transport and to determine the 
concentration of DPA at which such a mechanism becomes saturated. 
 Finally, a general, albeit statistically insignificant, decline in most PUFA was 
observed around d 28 in all diet groups.  In particular, plasma PL concentrations of AA 
and DHA were noticeably reduced on d 28 and gradually increased again by d 56.  This 
observation likely reflects the increased demand for and placental transfer of fatty acids to 
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the fetal puppies.  In humans, the placental transfer of AA and DHA begins around the 
onset of the third trimester and continues through the 40th wk, and fetal accretion of DHA 
is known to decrease maternal DHA status (49, 50, 218).  Detailed information on the 
mechanisms of placental transfer of nutrients in gestating canines currently is not known.  
However, the results of the present study indicate that the transfer of fatty acids may occur 
somewhat earlier in canines than in humans.  The reason for this is that the decrease in 
plasma PL PUFA occurred near the midpoint of gestation, rather than at the end of the 
second trimester, as in humans.  Further studies must be conducted to ascertain the time 
course and mechanisms of placental nutrient transfer in gestating dogs. 
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CHAPTER IV 
EFFECTS OF DIETARY ALA AND N-3 LCPUFA ON MATERNAL 
PLASMA PHOSPHOLIPIDS AND MILK DURING LACTATION IN 
CANINES 
Introduction 
 The n-3 and n-6 families of polyunsaturated fatty acids (PUFA) contain many 
biologically important lipids that are essential for proper growth, development, and general 
health maintenance. Brain and retinal functions depend on the n-3 polyunsaturate 
docosahexaenoic acid (22:6 n-3, DHA) not only during gestational development, but 
during postnatal life as well.  Maximal brain growth begins in the third trimester of 
gestation and continues throughout the first few months of neonatal life (42-44).  During 
this crucial period, there is a select accumulation of both arachidonic acid (20:4 n-6, AA) 
and DHA in brain and retina which occurs ten times faster than incorporation of their 
respective precursors, linoleic acid (18:2 n-6, LA) and alpha-linolenic acid (18:3 n-3, 
ALA) via chain elongation (47, 48).   In accordance with this knowledge, several authors 
have demonstrated that plasma DHA is the preferred substrate for retinal uptake in early 
developmental stages when the demand for DHA is greatest (78, 81, 83).   
Canine Neurologic Development 
 Docosahexaenoic acid is highly conserved in the retina, and it has a role in 
neurologic function in this tissue (83).  Canine retina is capable of synthesizing DHA from 
its 22-carbon precursor, docosapentaenoic acid (22:5 n-3, DPA) (58).   Bauer et al. (187) 
reported the accumulation of DPA, but not DHA, in canine plasma phospholipids when the 
precursor, ALA, is fed.  Therefore, it is likely that canine retina, and presumably other 
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nervous tissues, synthesize and utilize DHA in a manner similar to other mammalian 
species and that plasma DPA provides a likely substrate for such synthesis.  Thus, a dietary 
source of pre-formed DHA or one of its precursors may be necessary during gestation and 
suckling for normal neurodevelopment in dogs.   
 It is possible that ALA may be sufficient as a dietary precursor for the synthesis of 
requisite amounts of DHA during pre- and postnatal development.  However, what 
quantity of ALA may be needed to optimize neural development in companion animals 
currently is unknown.  Additionally, because both n-6 and n-3 fatty acids compete for the 
same enzyme systems, it also is unclear what relative amounts may be needed.    
Canine Milk Composition 
Early studies of canine milk composition were limited to macronutrient analysis 
and fatty acid analyses typically were not performed.  Thus, few reports exist regarding the 
fatty acid composition of canine milk (188, 190).   An effect of dietary LCPUFA intake 
during gestation and lactation on milk composition is expected; however, this effect has 
not been specifically investigated nor has a dose-response relationship been established.  
The purpose of the present study was to document diet effects of an 18-carbon n-3 
precursor, ALA, as well as LCPUFA on canine milk and maternal plasma when these fatty 
acids are included in gestation/lactation diets and to evaluate the possibility of a dose-
response with respect to dietary amounts of these fatty acids.   
Materials and Methods 
 An existing breeding colony of dogs provided bred hound/Labrador retriever dogs 
and their puppies for this study.  The colony contains a kindred of dogs with hereditary 
nephritis (214) but all dogs used in this study were clinically healthy.  Twelve dogs (three 
 69
each per diet group) were fed one of four complete and balanced, extruded-type diets from 
the time of insemination and throughout gestation, parturition, and lactation.  Sufficient 
quantities of the diets were fed to maintain weight gain in the latter stages of gestation by 
adjusting the amount fed as necessary.  The diets differed in their fatty acid composition 
and were sufficient in linoleic acid (Appendix B, Table B-I).  They contained 
approximately 15% total fat using either beef tallow, linseed oil, or higher and lower 
amounts of menhaden fish oil as primary fat source (Nestle-Purina PetCare, St. Louis).  
Using these dietary fat sources, diets were formulated using typical pet food ingredients to 
contain adequate LA ranging from 1.8 to 3.5 % dry matter (DM) with varying ratios of 
ALA/n-3 LCPUFA content and were designated as follows:  Lo/Lo (Lo ALA/Lo n-3 
LCPUFA), Lo/ Mod, Lo/Hi, and Hi/Lo.  All other dietary ingredients including total 
protein, nitrogen-free extract, vitamins, and minerals were identical, resulting in diets with 
similar nutrient concentrations except for fatty acid types (Appendix B, Table B-II). 
 After normal parturition, milk samples were collected from each dog by manual 
expression on lactation d 4, 10, 16, and 28.  Additionally, EDTA blood samples were 
collected on d 3 of gestation and on d 10 and 28 postpartum.  Plasma and milk total lipids 
were extracted using chloroform:methanol (2:1, v/v), fatty acid methyl esters prepared, and 
fatty acid profiles determined via gas chromatography (187).   Statistical analyses were 
performed by repeated measures ANOVA with Bonferroni multiple comparisons 
performed at p < 0.05.  However, more conservative p-values (p < 0.001) are presented 
where appropriate to show highly significant differences when they occurred.  Plasma PL 
fatty acid data from d 3 of gestation was included in the statistical analyses in order to 
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compare statistically significant differences between the end of lactation and the end of 
gestation. 
Results 
Maternal Plasma Phospholipids 
The fatty acid profiles of maternal plasma PL closely mirrored the fatty acid 
composition of the diets.  The percentages of major PUFA in maternal plasma PL are 
presented in Table 4.1.  Values from d 3 of gestation are included as a reference point for 
lactation.  Neither time nor diet*time effects were found for any fatty acid during the 
lactation period; however, there was a statistically significant difference in plasma AA and 
EPA content between gestation and lactation.  Furthermore, statistically significant diet 
effects were observed for most PUFA.     
 When the lactation samples were compared to d 3 of gestation (Table 4.1), a 
notable and statistically significant decrease in plasma PL AA content was observed.  
Significant increases in plasma PL EPA were also seen, but this is likely a reflection of 
increased substitution for AA. 
For all diet groups, the sample size was n=3 with the exception of the Lo/Mod 
group on d 10 of lactation.  Two of the samples for this time point evaporated during the 
methylation step, thus leaving only one sample available for analysis.  The maternal 
plasma PL content of major n-6 and n-3 PUFA are represented graphically in Figure 4.1.  
Because no time effects were found, data from both lactation days presented in these 
figures and in the text have been pooled.   
With respect to the n-6 PUFA, a dose response for LA was observed in maternal 
plasma.  The Hi/Lo diet contained 3.5% LA on a DM basis, which was more than twice the  
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Table 4.1 Relative percentage (mean + S.D.) of major PUFA in maternal plasma 
phospholipids during lactation 
  FATTY ACID 
DIET DAY 18:2 n-6 18:3 n-3 20:4 n-6 20:5 n-3 22:5 n-3 22:6 n-3 
G3 14.0 + 1.7 0.1 + 0.1 23.5 + 3.1a 0.3 + 0.0 1.7 + 0.2 0.5 + 0.2 
L10 16.8 + 2.8 0.2 + 0.1 8.6 + 1.3b 0.6 + 0.2 0.7 + 0.1 0.5 + 0.5 
Lo/Lo 
L28 14.2 + 4.1 0.1 + 0.1 7.5 + 3.4b 0.6 + 0.3 1.1 + 0.7 0.5 + 0.0 
G3 10.9 + 2.0 0.9 + 0.4 14.0 + 9.0 0.7 + 0.8 1.6 + 0.5 0.5 + 0.4 
L10 16.8 + 8.5 3.2 + 2.4 5.6 + 0.7 3.6 + 1.5 1.9 + 1.1 1.5 + 0.5 
Hi/Lo 
L28 20.2 + 3.3 2.8 + 1.5 5.9 + 1.1 4.0 + 1.9 2.9 + 0.3 2.1 + 1.1 
G3 10.2 + 1.1 0.1 + 0.1 24.2 + 3.7a 0.9 + 1.0a 2.4 + 0.3 1.5 + 0.9 
L10* 13.6 0.1 6.9b 6.1b 3.7 3.9 
Lo/Mod 
L28 16.9 + 0.3 0.2 + 0.0 4.7 + 0.1b 3.8 + 0.6ab 1.8 + 0.3 2.1 + 0.0 
G3 8.9 + 1.5 0.2 + 0.3 19.3 + 5.6a 3.8 + 2.3a 2.5 + 0.4 6.2 + 1.0 
L10 10.4 + 1.7 0.2 + 0.2 7.8 + 1.0b 9.2 + 0.9b 3.5 + 1.0 7.8 + 3.4 
Lo/Hi 
L28 8.7 + 4.1 0.0 + 0.0 5.6 + 1.5b 8.9 + 3.0b 3.3 + 1.8 7.2 + 4.6 
time 0.0163 0.0897 0.0000 0.0000 0.4819 0.3107 ANOVA 
(p) diet 0.0023 0.0000 0.0126 0.0000 0.0006 0.0000 
aMeans within a diet group with letters not in common differ with respect to time at p < 
0.05.  Differences due to diet are indicated in Figure 4.1.  (G3 = d 3 of gestation; L10 and 
L28 = d 10 and 28 of lactation, respectively). 
*Two of the samples in this group evaporated during methylation, thus leaving only one 
sample for analysis; n = 3 for all other groups. 
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Figure 4.1  Relative concentrations (mean + S.D.) of LA and AA (a) and  n-3 
PUFA (b) in plasma of dogs fed the experimental diets.  Dietary concentrations of LA in 
the diets are indicated on a % DM basis in (a).  The diets are designated as Lo/Lo, Lo/Mod, 
Lo/Hi, and Hi/Lo based on their ALA/n-3 LCPUFA contents.  Letters not in common for 
each fatty acid are significantly different at p < 0.05 (n = 3 per group). 
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amount contained in the Lo/Hi diet (Table B-I).  Consequently, the plasma PL LA of both 
these groups differed accordingly—the plasma PL of the Hi/Lo group contained 18.9 + 
5.2% S.D. LA and was roughly twice that of the Lo/Hi group.  No differences in plasma 
PL AA were observed during lactation, despite the up to two-fold difference in dietary LA.  
All diets contained nearly equal amounts of AA on a percent DM basis (Table B-I).   
More pronounced differences were observed in the n-3 PUFA.  The Hi/Lo diet 
contained 6.8% DM ALA, which ranged from nearly 25- to 50-fold higher than the other 
three diets.  Likewise, similarly large differences in plasma PL ALA were observed.  In the 
Hi/Lo group, the average plasma PL ALA during lactation was 2.7 + 1.6% S.D. of the total 
fatty acids, a value that was 10 to 30 times higher than, and significantly different from, all 
other diet groups.    
Plasma PL EPA and DHA were, expectedly, highest in the Lo/Hi diet group, which 
received the highest concentration of dietary n-3 LCPUFA.  Dietary EPA and DHA 
contents of 0.5% and 0.55% DM, respectively, resulted in much higher plasma PL 
concentrations of each fatty acid.  The mean plasma PL content of EPA was 9.1 + 2.0% 
S.D., while the mean plasma PL DHA content was 7.5 + 3.6% S.D.  In the Lo/Mod and 
Hi/Lo groups, dietary n-3 LCPUFA concentrations were quite different, yet plasma PL 
contents of both EPA and DHA were not statistically different between groups.  This 
finding provides evidence for the conversion of dietary ALA to longer-chain metabolites in 
vivo.  Moreover, these data demonstrate a dose-dependent response of plasma PL EPA and 
DHA to varying dietary amounts of these fatty acids.  The Lo/Lo diet group was fed the 
lowest amounts of ALA, EPA and DHA, which was manifested in the lowest plasma PL 
contents of EPA, DPA and DHA.  The maternal plasma PL concentrations of each of these 
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fatty acids were markedly lower in the Lo/Lo group than all other diet groups; however for 
DPA and DHA, these differences did not attain statistical significance.   
Canine Milk 
Canine milk contained, on average, 8.0 + 2.0% S.D. total fat on an as-is basis, and no 
significant differences due to diet or day of lactation were found.  Also, no main time effects 
were observed with respect to the individual fatty acids.  However, significant diet effects 
were observed among milk fatty acid contents in the groups. 
  Among the n-6 fatty acids, a dose response was seen for LA as a function of its 
dietary concentration.  Differences due to diet were statistically significant especially among 
the Lo/Lo, the Lo/Hi, and the Hi/Lo diet groups (Figure 4.2a).  However, in spite of a 
doubling of dietary LA contents and a modest increase in dietary AA, milk AA remained 
unchanged in all groups.  Dose responses of n-3 fatty acids in milk were also observed as a 
function of increasing dietary n-3 LCPUFA contents (Figure 4.2b).   Thus, as dietary EPA 
and DHA increased, statistically significant elevations of these fatty acids in milk were 
noted.  In the case of DPA, nominal increases were also seen, but the only statistically 
significant difference occurred between the Lo/Hi and Hi/Lo diets.    
Finding no enrichment of milk DHA in dogs fed the Hi/Lo diet (i.e., the ALA 
enriched diet) was of particular interest in this study.  This diet, which contained 6.8 % ALA 
DM basis, resulted in no significant differences in EPA, DPA, or DHA compared to the 
Lo/Lo diet that only contained 0.14 % ALA DM basis.  This was the case even though the 
Hi/Lo diet contained nearly 50-fold more ALA precursor of the n-3 LCPUFA.  Thus, no 
enrichment of canine milk n-3 LCPUFA occurs when ALA is fed during gestation and 
lactation. 
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Figure 4.2  Relative concentrations (mean + S.D.) of LA and AA (a) and n-3 PUFA 
(b) in canine milk in dogs fed the experimental diets.  Dietary concentrations of LA in the 
diets are indicated on a % DM basis in (a).  The diets are designated as Lo/Lo, Lo/Mod, 
Lo/Hi, and Hi/Lo based on their ALA/n-3 LCPUFA contents.  Letters not in common for 
each fatty acid are significantly different at p < 0.001.  Numbers not in common are 
significantly different at p < 0.05 (n = 3 per group). 
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Regression analysis revealed useful relationships between milk PUFA and dietary 
PUFA content (Figures 4.3 and 4.4).  Strong correlations existed for LA (r2 = 0.997), EPA  
(r2 = 0.999), and DHA (r2 = 0.988).  The resultant quadratic equations may be of use in 
formulating future canine gestation/lactation diets such that optimum PUFA enrichment in 
milk is obtained.  The predictive equations for each PUFA are listed below, where x = the 
dietary concentration of the respective fatty acid. 
Milk LA = 1.12x2  – 1.68x  + 7.05     (1) 
Milk EPA = -2.96x2  + 4.27x  + 0.48     (2) 
Milk DHA = -9.32x2 + 9.31x – 0.02     (3) 
 The best-fit curves in Figure 4.4 are close to 0% when dietary amounts of either EPA 
or DHA are also zero.  By contrast, milk (triacylglycerols) LA content is approximately 6 
relative% at a “theoretical” zero dietary LA.  Milk LA likely also reflects tissue stores of this 
fatty acid while EPA and DHA are not stored to any appreciable extent in triacylglycerols. 
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Figure 4.3  Regression analysis of milk LA vs. dietary LA.   
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Figure 4.4  Regression analysis of milk EPA (a) and DHA (b) vs. dietary EPA and 
DHA.   
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Discussion 
Maternal Plasma Phospholipids 
In this study the dietary LA content varied up to two-fold while the AA supply was 
relatively constant.  Consequently, the plasma PL content of LA varied in a dose-
dependent manner in response to dietary LA (Figure 4.1a).  However, although plasma AA 
among groups remained unchanged over time during lactation, there was a precipitous 
drop in plasma PL AA when lactation samples are compared with gestation.  Although 
reasons for this finding are unclear, it appears that this decrease may be related to the need 
to provide AA in milk fat for neonates during suckling.  Similar results among the n-3 fatty 
acids were not apparent in this regard, presumably because of the increased amounts of n-3 
fatty acids concomitantly supplied in the diets.   
Given the abundance of LA precursor, 3.5% DM, in the Hi/Lo group, it would not 
have been unreasonable to expect at least a modest increase in plasma AA in this group.  
Previous data, however, suggest that a competitive and “saturable” relationship exists 
between dietary PUFA and plasma PUFA in dogs (215).  Similar results have been 
obtained in humans (219).  The predictive equations for dog plasma devised by Bauer et al. 
(215) support the belief that adequate and saturable concentrations of dietary essential fatty 
acids in dogs may be as low as 0.5% energy.  Thus, any dietary concentration of LA 
greater than 0.5% energy would result in tissue saturation of AA.  Previous work 
determined the Km and Vmax of both LA and ALA for the ∆6 desaturase enzyme (216).  
Although the Km for LA is twice that of ALA, LA is present in greater amounts in canine 
diets and thus readily accumulates such that its Km is easily met.  In the present study, the 
lowest dietary LA content was 1.2% DM (0.8 en%), which was more than sufficient, 
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according to the derived prediction equations, to effect tissue saturation of AA.  Therefore, 
even when dietary LA was doubled, further increases in plasma AA did not occur. 
Also, substantial conversion of ALA to EPA and DPA occurred when large 
amounts of ALA were fed (Hi/Lo diet), yet the relative amounts of these LCPUFA 
remained significantly lower than those observed in the Lo/Hi group.  The Hi/Lo diet 
contained 6.8% ALA and minimal amounts of preformed n-3 LCPUFA, yet plasma PL 
EPA and DHA in this group were not significantly different from the Lo/Mod group, 
whose diet contained approximately 10 times the preformed n-3 LCPUFA of the Hi/Lo 
diet.  Unlike its n-6 counterpart, ALA is readily beta-oxidized and tends not to accumulate, 
in the absence of high dietary concentrations, to the extent required for conversion to 
occur.  Furthermore, once the Km for ALA is achieved, its rate of conversion (Vmax) is 
many times greater than the rate of conversion of LA (216).  However, in order to reach 
the Km for ALA, and for conversion to n-3 LCPUFA to proceed, the amount of dietary 
ALA must be exceedingly high (216).  The data presented here indicate that when dietary 
ALA is high (6.8% DM), the amounts of n-3 LCPUFA produced by conversion are 
roughly equivalent to the enrichment attained by feeding moderate amounts of EPA.   
The high ALA content of the Hi/Lo diet resulted in a product that had a strong 
varnish-like odor and at times was poorly received by many of the dogs in the study.  Such 
side effects must be taken into consideration when formulating diets that are intended to 
maximize n-3 LCPUFA metabolism.   
Although conversion of ALA undoubtedly occurs, it is many times less efficient 
than DHA at attaining a given degree of tissue enrichment. It has been demonstrated in 
various mammalian species that dietary DHA is a more effective source of tissue DHA 
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than dietary ALA (220).  A labeling study in young rats revealed a 20-fold difference in 
the recovery of radiolabeled DHA from labeled DHA versus DHA from a labeled ALA 
precursor (221).  Additional studies in baboons and guinea pigs suggest that 7 to 10 times 
more ALA than DHA is required to achieve equivalent tissue enrichment of DHA (48, 
222-224).   
Furthermore, ALA labeling studies in humans showed that the conversion of ALA 
to long-chain metabolites was 11-19% of the dose, and that conversion was decreased by 
as much as 54% when the diet was rich in LA (225).  The presence of large amounts of LA 
in the diet has been shown to suppress the expression of ∆6 desaturase, thus reducing the 
possibility for conversion of 18:3 n-3 (ALA) to 18:4 n-3 and 24:5 n-3 to 24:6 n-3 (226).  
Dietary LA in the Hi/Lo diet in this study was quite high, and thus could be a contributing 
factor to the poor conversion of ALA to long-chain metabolites beyond EPA.  
A dose-effect of fish oil was observed among the Lo/Lo, Lo/Mod and Lo/Hi diet 
groups.  As shown in Appendix Table B-I, the Lo/Hi diet contained roughly twice as much 
of each n-3 LCPUFA as did the Lo/Mod diet.  With the exception of DPA, this two-fold 
difference in n-3 LCPUFA was also present in the plasma PL of the respective diet groups.  
The differences in plasma PL DPA values were less pronounced than the differences in the 
other n-3 LCPUFA, and any dose-response observed was not statistically significant.  In 
the Lo/Hi group, plasma DPA was slightly, but not significantly, elevated with respect to 
the Lo/Lo, Lo/Mod and Hi/Lo diets.  One possibility for the less predictable behavior of 
DPA is that it may primarily be an intermediate between EPA and DHA and may be 
rapidly shunted toward other n-3 LCPUFA synthesis, which subsequently modifies its 
tissue accumulation at any given time. 
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Canine Milk 
Neither n-6 nor n-3 LCPUFA (i.e., AA, EPA, DPA, or DHA) become enriched in 
milk when their respective 18-carbon precursors are fed throughout gestation and lactation in 
dogs.  Similar small contributions of dietary LA to milk AA composition has been observed 
in humans using stable isotope techniques (227).   With respect to the n-3 fatty acids, only 
ALA was significantly increased in milk in response to dietary sources and no changes were 
seen in any of the derived n-3 LCPUFA.  This finding is also similar to that reported in 
humans by Francois et al. (157) in which seven lactating mothers ingested dietary flaxseed 
oil supplements at the rate of 20 g oil (10.7 g ALA) per day for 4 wk during lactation.  In that 
study, milk sample analyses were reported at baseline, 2 and 4 wk of supplementation and at 
4 wk post-supplementation.  In the present canine study, dogs were fed larger amounts of 
ALA approximating 18-37 g of ALA per day depending on stage of gestation or lactation.  
Nonetheless, no significant enrichment of milk DHA occurred at any time.  Francois et al. 
(157) did report that a modest yet statistically significant trend toward increased EPA and 
DPA was found over time.  However, inspection of their data show that the mean values of 
both EPA and DPA appeared to decrease from their modest increases at 2 wk by the 4 wk 
time period.  Thus it is possible that the milk samples of these subjects at 2 wk may not have 
been representative of a diet-supplement induced metabolic steady state.  Instead, they may 
have been a reflection to varying extents of the mothers’ previous diets, previous DHA 
status, or tissue stores immediately prior to beginning the dietary supplements (227).  Indeed 
our previous studies show that it will generally require more than 3-4 wk of dietary lipid 
modification to result in steady state plasma fatty acid concentrations (187).  Also, Francois 
et al. (157) supplemented human mothers only during lactation.  In the present study dogs 
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had been fed the high linseed oil diet (Hi/Lo diet) from the onset of breeding and throughout 
gestation (ca. 63 d) and lactation periods (ca. 28 d).  These differences may, in part, explain 
the modest elevations of EPA and DPA seen in human but not canine milk even though more 
ALA was fed to dogs in the present study. 
The finding that plasma PL AA significantly declined between the onset of 
gestation and the lactation period is potentially important in terms of AA being used to 
enrich milk during lactation and perhaps during fetal development as well.  The plasma PL 
fatty acid content at d 3 of gestation does not necessarily reflect only the experimental 
diets, but, to some extent, the pre-breeding diets as well.  However, the LA and AA 
contents of the pre-breeding diet were not broadly different from those used in this study.  
Thus, this decrease likely is not attributable to dietary differences per se. 
An additional consideration is the fact that the experimental diets contained n-3 fatty 
acids, which also may contribute to the lowering of AA in plasma PL.  However, AA content 
decreased by 100% in each case, including the Lo/Lo diet, which was nearly devoid of n-3 
PUFA.  Thus, it appears that a marked decrease occurs in plasma PL AA in gestating (non-
lactating) canines compared to lactation.  Such an effect may reflect AA incorporation into 
the milk, which would assure delivery of this important fatty acid to the developing neonate. 
The observations that dietary LA did not increase AA and that dietary ALA did not 
increase milk n-3 LCPUFA support the possibility that the biosynthetic pathways 
specifically relating to desaturation and chain elongation of milk lipids are poorly developed 
in canine mammary tissue.  An alternate explanation is that these pathways are competitively 
inhibited in the presence of either small dietary amounts of the LCPUFA or their existing 
tissue stores.  In either case, supplementation of gestation/lactation diets with LA or ALA 
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does not appear to be an effective method of increasing milk fat LCPUFA for developing 
canines.   
In summary, dietary ALA supplementation during gestation/lactation is an ineffective 
means of increasing milk DHA content to supply dietary amounts of this LCPUFA for 
neonatal nutritional modification.  Whether sources of pre-formed dietary n-3 LCPUFA are 
necessary to support puppy development during suckling or whether puppies are themselves 
capable of synthesizing sufficient n-3 and n-6 LCPUFA from 18-carbon precursors is a 
question that was also addressed in the present study and which will be reported in Chapter 
V of this dissertation.  Finally, the consistency of the milk AA concentration independent of 
dietary LA content and the dose responses seen with the n-3 LCPUFA will assist in future 
efforts to approximate dietary PUFA amounts needed to support specific milk PUFA 
concentrations for puppies during suckling.  However, it should be noted that exact amounts 
that are most beneficial for puppies themselves remains undetermined.     
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CHAPTER V 
EFFECT OF DIETARY ALA AND N-3 LCPUFA ON PLASMA 
PHOSPHOLIPIDS AND ON ELECTRORETINOGRAM (ERG) 
PARAMETERS IN YOUNG CANINES 
Introduction 
 In the last 20 years, the importance of n-3 fatty acids in brain and retinal 
development has become increasingly evident.  One question that remains, however, is 
whether ALA provided as a precursor is sufficient for optimal development or if preformed 
DHA is required.  The greatest concern is for premature infants, whose intrauterine 
development is shortened, often by several weeks (26).   
 Neural development in primates begins in the third trimester of gestation, peaks 
about the time of birth, and continues for about 18-24 months after parturition (49, 50).  
During this developmental period, AA and DHA are rapidly incorporated into the neural 
tissues (47, 48).  The high amounts of DHA in the brain and especially in the retina suggest 
a functional role in these tissues (108).  Deficiency of n-3 PUFA during the developmental 
phase in neural tissues can result in irreversible functional abnormalities.  
Electroretinogram (ERG) data from humans and monkeys indicate decreased amplitudes 
and increased implicit times of both the a- and b-waves in response to n-3 PUFA 
insufficiency (126, 136).  Reduced a- and b-wave amplitudes have also been reported in n-
3 deficient rats; however, retinal function was restored when the rats were fed n-3 replete 
diets (54). 
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Canine Neurologic Development 
 DHA is highly conserved in the retina, and it has a role in neurologic function in 
this tissue (83).  Canine retina is capable of synthesizing DHA from its 22-carbon 
precursor, docosapentaenoic acid (22:5 n-3, DPA) (58).   Bauer et al. (187) reported the 
accumulation of DPA, but not DHA, in canine plasma phospholipids when the precursor 
ALA is fed.  It, therefore, is likely that canine retina, and presumably other nervous tissues, 
synthesize and utilize DHA in a manner similar to other mammalian species and that 
plasma DPA provides a likely substrate for such synthesis.  Thus, a dietary source of pre-
formed DHA or one of its precursors may be necessary during gestation and suckling for 
normal neural development in dogs.   
 It is possible that ALA may be sufficient as a dietary precursor for the synthesis of 
requisite amounts of DHA during pre- and postnatal development.  However, what 
quantity of ALA may be needed to optimize neural development in companion animals 
currently is not known.  Additionally, because both n-6 and n-3 fatty acids metabolically 
compete for the same enzyme systems, it also is unclear what relative amounts may be 
needed.    
The Electroretinogram 
Electroretinography is a sensitive and quantitative measure of retinal function in 
humans and animals (228, 229).  The ERG recording represents the response of the 
photoreceptors, and their subsequent post-synaptic signals, to a series of varying-intensity 
flash stimuli.  It is the sum of responses across the retina and includes the responses of 
many retinal cell types.  Major ERG components have been studied in dogs (230), and 
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many studies suggest the use of the dog as a suitable model for the study of human retinal 
physiology and pathology (231). 
One goal of this study was to assess the effect of dietary n-3 fatty acid supply on 
retinal function in canine neonates.  To our knowledge, such a study has not been reported.   
Materials and Methods 
 An existing breeding colony of dogs provided bred hound/Labrador retriever dogs 
and their puppies for this study.  Twelve dogs (3 each per diet group) were fed one of four 
complete and balanced, extruded-type diets from the time of insemination and throughout 
gestation, parturition, and lactation.  These diets have been described in detail in Chapter 
II.  Fatty acid compositions and nutrient contents of the diets can be found in Appendix B, 
Tables B-I and B-II.  After parturition, puppies were allowed to suckle ad libitum.  At 21 d 
postpartum, a gruel consisting of the mothers’ respective diets and water was offered to the 
puppies three times a day, in addition to suckling.  Gradually, the time the puppies spent 
suckling was decreased until they were completely weaned by d 28.  Upon weaning, 
puppies were continued on the same diets as their mothers until 12 wk of age.  The puppies 
were weighed daily until 6 wk of age and every other day thereafter to ensure proper 
growth and development.  If any failure-to-thrive issues arose, the puppy was removed 
from the study and supplemented to ensure proper nutrition.  Generally this occurred only 
when litter size was large; small puppies were the most likely to be removed. 
EDTA blood samples were taken from the puppies on d 4, 10, 16, 28, 70 and 84 of 
age.  The puppies were removed from their mothers three hours prior to blood collection 
on d 4, 10, 16 and 28, and food was withheld overnight on d 70 and 84.  Two milliliters of 
blood was taken on each sample day through d 16. On d 28, 4 mL were collected, and on 
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days 70 and 84, 7 mL were obtained.  Plasma total lipids and erythrocyte total PL were 
extracted using chloroform:methanol (2:1, v/v) and subsequently separated into subclasses 
via thin-layer chromatography.  Fatty acid methyl esters were prepared, and fatty acid 
profiles were determined via gas chromatography (187).   Statistical analyses were 
performed by repeated measures ANOVA with Bonferroni comparisons performed at p < 
0.05 for plasma PL fatty acids.   
At 12 wk of age, retinal development of the puppies was assessed via 
electroretinography (ERG).  The ERG procedure is outlined in detail in Chapter II.   The 
completion of the ERGs marked the end of the study, at which time suitable homes were 
found for the puppies.  Statistical analyses were performed on ERG parameters using data 
obtained from the 8th flash intensity via one-way ANOVA with Bonferroni comparisons 
performed at p < 0.05. 
An additional parameter, ä, was derived from the slope of the a-wave (140).  The 
ERG software used in the study calculated the slopes of the descending limb of the a-wave 
for the three highest intensity responses; the increase in magnitude of these slopes as a 
function of intensity is reported as the parameter ä. The slope for each of the three 
intensities was then plotted against flash intensity.  The resultant data were modeled with 
linear regression to yield ä as the calculated slope parameter (140).  The slope ä represents 
the increase in initial response with increasing light intensity (232). 
Results 
 Because no time effects were observed for any fatty acid, numerical values reported 
in the text and presented in figures are mean values for all four sample days during 
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suckling and both sample days during the postweaning period.  The experimental unit was 
“litter,” and n = 3 for each diet group. 
Suckling Period 
A dose response of dietary LA (from milk) was observed in neonatal plasma 
(Figure 5.1a).  Milk from the Hi/Lo group contained the highest concentration of LA 
(Table 5.1); consequently so did plasma PL from neonates in this group.   Plasma PL 
arachidonate in neonates from the Lo/Lo group, was significantly higher than all other 
groups (Figure 5.1a).  A summary of the mean plasma PL content of major fatty acids 
during suckling is presented in Table 5.2.  Values presented are mean values for each 
sample day during the suckling period.   
Table 5.1  Mean + S.D. dietary content (in milk) of major fatty acids during suckling 
FATTY ACID 
DIET 18:2 n-6 20:4 n-6 18:3 n-3 20:5 n-3 22:5 n-3 22:6 n-3 
Lo/Lo 7.27 + 1.63a 0.81 + 0.35 0.63 + 0.40a 0.53 + 0.44a 0.63 + 0.52ab 0.30 + 0.25a
Lo/Mod 10.5 + 2.23b 0.70 + 0.22 1.42 + 1.20a 1.18 + 0.24b 0.88 + 0.40ab 1.41 + 0.69b
Lo/Hi 6.73 + 2.20a 0.74 + 0.34 1.54 + 1.62a 1.87 + 0.53c 1.00 + 0.24a 2.28 + 0.88c
Hi/Lo 14.8 + 1.58c 0.73 + 0.17 22.3 + 7.53b 0.59 + 0.21a 0.35 + 0.37b 0.19 + 0.34a
Letters not in common for individual fatty acids are significantly different at p < 0.05 (n = 
3 dogs per group).  Mean milk fat concentration was 8.0 + 2.0 % on an as-is basis. 
  
With respect to the n-3 fatty acids, dose responses were observed for ALA, EPA 
and DHA.  Puppies in the Hi/Lo group received the largest relative amount of ALA in their 
diets (22.3 + 7.5% S.D.), and their plasma PL also contained the highest concentration of 
ALA, 1.3 + 0.7% S.D.  These values were significantly different from all other diets at p < 
0.05.  Neither dietary nor neonatal plasma ALA were different among the remaining 
dietary groups (Figure 5.1b). 
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Table 5.2  Relative percent (mean + S.D.) of major n-6 and n-3 fatty acids in neonatal 
plasma PL during suckling 
 FATTY ACID 
DIET DAY 18:2 n-6 20:4 n-6 18:3 n-3 20:5 n-3 22:5 n-3 22:6 n-3 
4 13.2 + 0.5 15.0 + 2.7 0.2 + 0.1 0.1 + 0.1 0.6 + 0.1 1.0 + 0.4 
10 14.1 + 2.7 13.9 + 2.4 0.2 + 0.1 0.2 + 0.0 0.8 + 0.0 1.1 + 0.3 
16 15.2 + 0.9 13.6 + 1.5 0.2 + 0.1 0.2 + 0.0 0.9 + 0.4 1.2 + 0.1 
Lo/Lo 
28 9.4 + 1.0 11.7 + 3.9 0.1 + 0.0 0.3 + 0.1 0.7 + 0.2 1.2 + 0.4 
4 18.2 + 0.9 11.2 + 1.9 0.87 + 0.4 1.1 + 0.6 1.4 + 0.4 2.7 + 0.2 
10 20.0 + 2.4 9.1 + 1.2 1.4 + 0.1 1.6 + 0.7 1.5 + 0.1 3.8 + 0.1 
16 18.1 + 4.0 8.9 + 1.4 1.1 + 0.6 1.8 + 0.8 1.8 + 0.3 4.3 + 0.7 
Hi/Lo 
28 16.5 + 3.1 9.8 + 1.4 1.9 + 1.2 2.2 + 0.3 1.7 + 0.3 5.6 + 2.0 
4 13.3 + 2.5 10.8 + 1.0 0.3 + 0.1 1.3 + 0.5 1.3 + 0.3 7.2 + 0.6 
10 12.4 + 2.7 8.1 + 1.7 0.6 + 0.4 1.5 + 0.3 1.0 + 0.3 5.9 + 1.1 
16 15.5 + 0.6 8.7 + 4.1 0.04 + 0.08 3.3 + 2.4 1.3 + 0.5 6.7 + 1.4 
Lo/Mod 
28 14.8 + 1.6 8.8 + 1.8 0.09 + 0.08 2.5 + 1.1 1.2 + 0.5 5.7 + 1.2 
4 9.2 + 2.1 8.5 + 0.8 0.03 + 0.05 2.0 + 1.2 1.2 + 0.2 5.2 + 1.9 
10 10.3 + 0.05 9.6 + 1.4 0.1 + 0.2 5.4 + 1.8 1.5 + 0.5 9.3 + 2.9 
16 9.3 + 2.2 10.1 + 4.4 1.2 + 2.0 4.1 + 0.7 2.2 + 1.3 10.3 + 3.5 
Lo/Hi 
28 8.6 + 0.2 7.8 + 0.2 0.1 + 0.2 6.7 + 1.9 1.7 + 0.3 11.2 + 3.9 
time 0.0597 0.2850 0.7250 0.0024 0.0537 0.0663 ANOVA 
(p) diet 0.0000 0.0001 0.0002 0.0000 0.0000 0.0000 
No time effects within diet groups were observed at p < 0.05 (n = 3 litters per diet group).  
Dietary differences for individual fatty acids are indicated in Figure 5.1.   
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Figure 5.1  Mean plasma PL content of LA and AA (a) and major n-3 fatty acids 
(b) during suckling.  Because no time effects were observed for any fatty acid, data from 
all four sample days during suckling were pooled.  Letters not in common for individual 
fatty acids are significantly different with respect to diet at p < 0.05 (n = 3 litters per diet 
group). Error bars indicate S.D. values. 
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Milk EPA and DHA were highest in the two fish-oil diet groups.  Likewise 
neonatal plasma from these groups contained the largest amounts of EPA and DHA in the 
PL fraction (Figure 5.1b).  Neonatal plasma PL from the Lo/Hi group contained 4.6 + 2.2% 
S.D. EPA compared to 2.2 + 1.4% S.D. in the Lo/Mod group.  These values were 
significantly different from each other as were the concentrations of dietary (milk) EPA in 
these two groups.   
Despite a two-fold, and statistically significant, difference between milk EPA in the 
Lo/Mod and Hi/Lo groups, the EPA in plasma PL from neonates in these groups were not 
significantly different.  However, milk ALA differed considerably between these two diet 
groups.  Mean plasma PL EPA from puppies in the Hi/Lo group was 1.7 + 0.7% S.D. 
(Figure 5.1b). 
 Dietary (milk) DPA was highest in the two fish-oil groups and lowest in the Hi/Lo 
group (Table 5.1).  However, DPA concentrations in plasma PL were similar between the 
Hi/Lo and Lo/Mod groups, with values of 1.6 + 0.3% S.D. and 1.2 + 0.3% S.D., 
respectively.  Puppies in the Lo/Hi group had the highest plasma PL DPA content, 1.59 + 
0.59%, while the Lo/Lo group had the lowest, 0.77 + 0.23%.  None of these differences 
attained statistical significance (Figure 5.1b). 
 A dose response of DHA was also observed in the plasma of puppies fed diets 
containing n-3 LCPUFA.  DHA concentrations in plasma PL were 9.0 + 3.6% S.D., 6.4 + 
1.2% S.D. and 1.1 + 0.3% S.D, respectively, in the Lo/Hi, Lo/Mod and Lo/Lo groups.  
Puppies in the Hi/Lo group received the lowest relative amount of DHA in milk, yet their 
plasma PL contained fairly high amounts, 4.10 + 1.44%, of this fatty acid.  Plasma DHA 
concentrations in all diet groups were significantly different from each other at p < 0.05. 
 93
Post-weaning Period 
 Plasma PL fatty acid profiles of the puppies consuming the dry diets were similar 
to those obtained during suckling.  Fatty acid compositions of the dry diets can be found in 
Appendix B, Table B-I.  A dose response was again observed for LA (Figure 5.2a).  An 
interesting occurrence was the significantly higher arachidonate concentration in the 
plasma PL of Lo/Lo puppies.  This finding is peculiar because all groups received similar 
(not significantly different) amounts of AA in both the milk and dry diets.  Moreover, the 
Hi/Lo diet contained the greatest concentration of LA, which was up to two times higher 
than the LA content of the remaining three diets.  This apparent “increase” in plasma AA 
in the Lo/Lo group is most likely the result of a decrease in plasma AA due to competition 
from n-3 PUFA in the other three groups such that the plasma AA content in Lo/Lo 
puppies appears elevated relative to the others.  A summary of the mean plasma PL content 
of major fatty acids after weaning is presented in Table 5.3.  Values presented are mean 
values for each sample day during the post-weaning period.   
 The Hi/Lo group again had significantly higher ALA, 2.2 + 0.4% S.D., in plasma 
PL (Figure 5.2b).  The other three groups, whose plasma PL ALA was on the order of 
0.15% of total fatty acids, were not significantly different from each other. 
 The Hi/Lo group also had the highest concentrations of EPA and DPA in the 
plasma PL fraction (Figure 5.2b).  Mean EPA during the post-weaning period was 6.8 + 
1.8% S.D. in the Hi/Lo group, compared to 3.9 + 1.8% S.D. and 6.0 + 3.2% S.D.,  
respectively, in the Lo/Mod and Lo/Hi diet groups.  These values, however, were not 
statistically different from each other.  Plasma PL fatty acids from puppies in the Lo/Lo 
diet group contained considerably less EPA, 0.2 + 0.1% S.D., yet due to considerable  
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Table 5.3  Relative percent (mean + S.D.) of major n-6 and n-3 fatty acids in neonatal 
plasma PL after weaning 
 FATTY ACID 
DIET DAY 18:2 n-6 20:4 n-6 18:3 n-3 20:5 n-3 22:5 n-3 22:6 n-3 
70 11.0 + 2.3 18.9 + 4.0 0.2 + 0.1 0.3 + 0.0 1.3 + 0.4 1.5 + 0.4 
Lo/Lo 
84 10.5 + 3.8 16.9 + 6.9 0.2 + 0.1 0.6 + 0.1 1.4 + 0.2 1.2 + 0.6 
70 17.0 + 2.3 7.2  + 1.9 2.3 + 0.6 6.5 + 1.7 2.1 + 0.1 1.5 + 0.4 
Hi/Lo 
84 16.1 + 2.3 7.1 + 2.1 2.2 + 0.2 7.1 + 2.3 2.2 + 0.5 1.2 + 0.3 
70 11.8 + 0.6 8.3 + 2.7 0.2 + 0.02 3.5 + 1.7 1.6 + 0.7 4.7 + 2.5 
Lo/Mod 
84 13.4 + 0.2 11.1 + 2.7 0.1 + 0.1 4.4 + 2.1 2.1 + 1.2 7.4 + 5.5 
70 7.9 + 0.2 6.9 + 2.8 0.2 + 0.05 5.7 + 3.1 2.1 + 1.1 5.0 + 2.5 
Lo/Hi 
84 6.6 + 0.3 6.4 + 2.6 0.1 + 0.02 6.3 + 4.0 2.0 + 1.1 7.4 + 5.1 
time 0.7391 0.9623 0.5636 0.6279 0.6021 0.3007 ANOVA 
(p) diet 0.0000 0.0000 0.0000 0.0004 0.3245 0.0032 
No time effects within diet groups were detected at p < 0.05 (n = 3 litters per diet group).  
Dietary differences for individual fatty acids are indicated in Figure 5.2. 
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 Figure 5.2  Mean plasma PL content of LA and AA (a) and n-3 fatty acids (b) after 
weaning.  Because no time effects were observed for any fatty acid, data from both sample 
days were pooled.  Letters not in common for individual fatty acids are significantly 
different with respect to diet at p < 0.05 (n = 3 litters per diet group).  Error bars indicate 
S.D. values. 
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variability in individual responses, this difference was not significantly different from 
puppies in the Lo/Mod group.  In addition, statistical differences in plasma PL DPA 
concentrations were not observed amongst diets at p < 0.05.  
 During the post-weaning period, a dose response of fish oil was not as apparent in 
the plasma of the Lo/Lo, Lo/Mod and Lo/Hi puppies.  This observation is in contrast to 
data from other parts of this study in which a dose effect of DHA was clearly observed in 
the plasma of both mothers and neonates from these diet groups.  Plasma PL DHA content 
in the fish-oil groups were significantly higher than the remaining two groups, but were not 
significantly different from each other because of the large sample variability.  Mean 
plasma PL DHA concentrations during the post-weaning period were 6.2 + 3.8% S.D. and 
6.1 + 4.1% S.D., respectively, in the Lo/Hi and Lo/Mod groups (Figure 5.2b).  These 
values compared with 1.3 + 0.4% and 1.3 + 0.5% S.D., respectively in the Hi/Lo and 
Lo/Lo diet groups.  The failure of the Lo/Mod and Lo/Hi groups to attain statistical 
significance can be attributed to the large variability in individual responses.  
Red blood cell phospholipids.  Although RBC data were incomplete, total PL 
fatty acid profiles from at least one litter per diet were available for the d 28 and wk 12 
sample days.  Difficulties with implementing reliable separation of phospholipid 
subfractions for subsequent analyses resulted in the loss of a majority of the RBC samples.  
Small sample volumes did not allow further sample analysis of total RBC PL. 
Mean RBC DHA content on d 28 was highest in the Lo/Hi group (5.8%, n=1), 
followed by the Hi/Lo (n = 2), Lo/Mod (n = 1), and Lo/Lo (n = 2) groups whose mean 
RBC DHA content were 2.6 + 1.0% S.D., 2.1%, and 1.4 + 1.3% S.D., respectively.  At wk 
12 the Lo/Hi group (n = 2) again had the highest DHA content, 4.3 + 0.8% S.D.  Among 
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the remaining groups, erythrocyte DHA content was 3.1% in the Lo/Mod group (n = 1), 
2.8% in the Hi/Lo group (n = 1).  Puppies in the Lo/Lo group (n = 1) had only trace 
amounts of DHA in the RBC fraction.   
Because of the limited data available for the RBC PL fatty acid profiles, valid 
estimates of retinal DHA content at 12 wk of age cannot be made.  However, from the 
available data, it appears that RBC DHA content was greatest in the Lo/Hi puppies and 
lowest in the Lo/Lo puppies, while the Lo/Mod and Hi/Lo groups were intermediate.  Due 
to the small sample size, there were not enough degrees of freedom to declare statistical 
significance.   
Electroretinography 
Retinal function was assessed at 12 wk of age via flash electroretinography.  A 
representative ERG is shown in Figure 5.3.  Parameters of interest were the a- and b-wave 
amplitudes (a-amp and b-amp, respectively), the implicit times of the a- and b-waves (ai 
and bi, respectively), and the derived parameter ä.  Statistical analyses were performed on 
data obtained at the eighth light intensity because the highest intensity is known to saturate 
the rod response in canines (213).  A summary of these parameters, including sample sizes, 
is presented in Table 5.4. 
The puppies in the Lo/Hi group demonstrated the greatest response in their a-
waves.  Mean a-amp in this group was 49.5 + 16.3µV S.D.  This value was not 
significantly different from the mean a-amp of the Hi/Lo group, which was 43.5 + 18.4µV  
S.D.  Both groups, however, were significantly different from the Lo/Mod and Lo/Lo 
groups, which had mean a-amp of 24.6 + 8.8µV S.D. and 31.6 + 19.6µV S.D., respectively. 
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 Figure 5.3  An ERG series from a puppy in the Lo/Hi group.  The intensity of the 
stimulus increased in half log-unit steps, eliciting ERGs starting from the bottom.  For all 
animals, the amplitudes and implicit times of both the a- and b-waves were determined at 
the 8th (third most intense) flash intensity.  Mean values are reported in Table 5.4.  The ä is 
calculated from the top three a-wave slopes only.
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Table 5.4  Mean + S.D. values for ERG parameters obtained at 8th  light intensity 
DIET 
a-amp 
(µV) 
b-amp 
(µV) 
ai 
(ms) 
bi 
(ms) ä 
Threshold
Intensity 
Lo/Lo 
n=36 31.6 + 19.6
a 172.3 + 60.0ab 6.1 + 2.3a 35.5 + 4.1a 1.8 + 1.0a 6.2 + 1.0a
Lo/Mod 
n=25 24.6 + 8.8
a 153.2 + 49.5b 5.6 + 1.5ab 34.9 + 2.9a 1.6 + 0.5a 5.8 + 0.8ab
Lo/Hi 
n=20 49.5 + 16.3
b 197.8 + 47.5a 4.4 + 1.2b 33.0 + 4.3ab 2.5 + 1.0b 5.3 + 0.6b
Hi/Lo 
n=30 43.5 + 18.4
b 169.7 + 42.6ab 5.0 + 1.4ab 32.1 + 3.2b 1.9 + 0.7ab 5.9 + 0.8a
p-value 
(ANOVA) 0.0000 0.0350 0.0026 0.0013 0.0066 0.0017 
Letters not in common for a given parameter are significantly different at p < 0.05. 
 
 
Mean ai was lowest in the Lo/Hi group and highest in the Lo/Lo group.  Implicit 
times were not significantly different among the Lo/Mod, Lo/Hi and Hi/Lo diet groups, 
whose mean ai were 5.6 + 1.5 ms S.D., 4.4 + 1.2 ms S.D., and 5.0 + 1.4 ms S.D., 
respectively.  The ai of the Lo/Lo group was 6.1 + 2.3 ms S.D., which was not significantly 
different (p < 0.05) from values obtained in the Lo/Mod or Hi/Lo groups.   
 The ä parameter, as described by Breton et al. (140, 232), is a measure of the time-
course of activation of the phosphodiesterase cascade in the rod outer segments (ROS).  
Because the calculation of ä is based on the a-amp, the results obtained follow a similar 
pattern as those obtained for the a-amp.  Again, visual performance in the Lo/Hi group was 
significantly greater than the Lo/Lo and Lo/Mod groups. Values of ä for these groups were 
2.5 + 1.0, 1.8 + 1.0, and 1.6+ 1.5, respectively.  The value of ä in the Hi/Lo group was 1.9 
+ 0.7, which was not significantly different from any other dietary group.   
Dietary content of LCPUFA did not appear to have a direct effect on either of the 
b-wave parameters.  The greatest b-amp, 197.8 + 47.5µV, was observed in the Lo/Hi 
group, followed by the Lo/Lo, Hi/Lo and Lo/Mod groups, respectively.  On average, 
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puppies in the Hi/Lo group elicited the quickest b-wave response (lowest mean bi), at 32.1 
+ 3.2 ms, which was significantly different from the Lo/Lo and Lo/Mod groups.  The mean 
bi of puppies in the Lo/Hi group was 33.0 + 4.3 ms, while the mean bi of the Lo/Lo and 
Lo/Mod groups was 35.5 + 4.1 ms and 34.9 + 2.9 ms, respectively.  No significant 
differences were detected among these latter three diet groups at p < 0.05.    
 Not all animals responded equally to all intensities of light.  Some puppies did not 
elicit an a-wave response until the 7th or 8th flash intensity, whereas others responded as 
early as the 4th flash intensity.  Based on this observation, mean values were obtained for 
the threshold intensity (It), which was the intensity at which the a-wave was first detected.  
To our knowledge, such a parameter has not been reported before.  On average, the Lo/Hi 
group responded to flashes at lower intensities than did the other three groups.  The 
Lo/Mod and Lo/Hi diet groups were not significantly different from each other, but the 
Lo/Hi group was significantly different from the Lo/Lo and Hi/Lo groups (Table 5.4).   
Discussion 
Plasma Phospholipids 
For the first 21 d of the suckling period, maternal milk served as the sole source of 
nutrition for the neonates.  By 28 d of age, the puppies had been weaned onto the same 
experimental diets as their mothers.  With few exceptions, the plasma PL fatty acid profiles 
from both the suckling and post-weaning periods were not different.   
 The response of neonatal plasma PL composition to dietary fatty acids is similar to 
that observed in adult dogs during the gestation and lactation portions of this study.  Dose 
responses were observed for LA and ALA in all neonates and for DHA in the Lo/Lo, 
Lo/Mod and Lo/Hi groups.   
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 The puppies in the Hi/Lo and Lo/Lo groups received nearly identical amounts of 
EPA from mothers’ milk, yet the concentration of EPA in the plasma PL of the Hi/Lo 
puppies was many times higher than that of the Lo/Lo puppies.  Although the differences 
between the Hi/Lo and Lo/Mod puppies in plasma PL concentrations of EPA were 
statistically significant, EPA in the Hi/Lo puppies compared more closely with that of the 
Lo/Mod puppies, whose diet contained twice the EPA, than with the Lo/Lo puppies.  
Furthermore, milk DHA in the Hi/Lo group was the lowest among all four groups, yet the 
plasma PL from these puppies contained markedly elevated concentrations of DHA.  From 
these data, it is apparent that neonatal canines are indeed capable of synthesizing EPA and 
DHA from ALA.  This is consistent with results from studies in human infants, which have 
reported the ability of both fetuses and neonates to synthesize LCPUFA from their 18-C 
precursors (17-21).  Additionally, when adult dogs are fed high dietary amounts of ALA, 
there is little additional accumulation of PL DHA in plasma (187, 233), yet neonates 
appear to have considerable PL DHA in their plasma under similar dietary conditions.  
Although reasons for this are unknown, it appears that neonatal canines may preferentially 
synthesize at a time of life in which demand is especially high.  Peroxisomal metabolism in 
young dogs may be increased compared to adults, whereby DPA is more readily converted 
to DHA. 
 Mean plasma PL AA in the Lo/Lo group was significantly higher than all other 
groups during both the suckling and post-weaning periods.  This occurred despite the facts 
that no significant dietary differences existed in milk AA and that all experimental diets 
contained nearly identical amounts of AA.  This perceived “enrichment” was the result of a 
blunting of AA incorporation into plasma PL by increased concentrations of n-3 LCPUFA 
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in the Lo/Mod, Lo/Hi and Hi/Lo diets.  When n-3 PUFA content is high, EPA will be 
substituted for AA in PL.  Thus, the Lo/Lo diet group was not necessarily enriched in AA; 
instead, the other diet groups had decreased AA and increased n-3 PUFA.  Another 
possible explanation for the increased plasma PL arachidonate is that the low concentration 
of dietary ALA facilitated increased rates of elongation and desaturation of LA by means 
of reduced competition for ∆6 desaturase.  A study of ∆6 desaturase enzyme kinetics in 
adult canine liver microsomes reported that, despite its twofold larger Km, LA is readily 
converted to long-chain metabolites in the absence of high dietary amounts of ALA (215).  
Since most canine diets are replete in LA, and physiological concentrations of ALA are 
typically much less than its Km, elongation of LA usually proceeds unhindered.  This 
competition for ∆6 desaturase is of particular concern in developing neonates.  Therefore, 
careful consideration must be taken when formulating infant formula, either for dogs or 
humans, in order to assure adequate tissue enrichment of both n-6 and n-3 LCPUFA, 
which may be conditionally essential during the perinatal period. 
 Noted differences in the plasma distribution of EPA were observed between the 
suckling and post-weaning periods.  During suckling, the Lo/Hi and Lo/Mod diet groups 
were significantly different from each other, and both were significantly higher than the 
Hi/Lo group.  However, after weaning, the Hi/Lo group contained the highest 
concentration of EPA in plasma PL.  Although this value was markedly increased from 
suckling values, the difference was not significant due to large variability of the response.  
The lower plasma EPA during suckling may indicate a more efficient conversion of ALA 
to DPA and DHA in younger puppies, when the demand for DHA is greatest.  After 
weaning, demand for DHA by neural tissues is decreased and EPA accumulates.  This is 
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consistent with studies of human infants that suggest LCPUFA formation is a function of 
gestational age, and that the elongation/desaturation machinery is more active at earlier 
gestational ages (29).   
 A dose response of DHA was observed among the Lo/Lo, Lo/Mod and Lo/Hi 
groups during suckling; however, this effect was not evident in post-weaning plasma PL.  
Concentrations of DHA in plasma PL were nearly identical between the Lo/Mod and 
Lo/Hi groups 6 to 8 wk after weaning, despite the two-fold difference in total dietary n-3 
LCPUFA.  However, marked variability was again observed in post-weaning plasma 
samples from these two groups.   
Additionally, the enrichment of DHA in plasma PL of the Hi/Lo group did not 
parallel the increase in plasma EPA in this group during the post-weaning period.  This 
finding emphasizes the fact that feeding diets rich in ALA results in the enrichment of 
DPA in plasma PL, especially in older dogs.  Bauer et al. (187) also reported the 
accumulation of plasma DPA, but not DHA, in adult dogs fed flaxseed oil (10 wt% ALA) 
diets.  Although DHA is not enriched in the plasma, tissue needs may still be met by 
further conversion of DPA.  This conversion, however, is far less efficient at enriching 
tissue DHA than when preformed DHA is supplied in the diet.  Fu and Sinclair (234) 
reported that guinea pigs fed a high-ALA (17% total FA) diet had significantly more whole 
body ALA and EPA, but not DPA or DHA, compared to those fed a low-ALA (0.3% total 
FA) diet.  Similarly, humans fed 15 g ALA/day for 4 wk experienced small, but significant 
increases in the PL content of ALA, EPA, and DPA, but little to no increase in DHA in 
plasma, platelets, white blood cells and erythrocytes (235-237).  However, in these studies, 
accumulation of DHA in neural tissues was not measured.  Moreover, studies in guinea 
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pigs and baboons have shown that dietary DHA was ten and seven times, respectively, as 
effective as a substrate for neural DHA than dietary ALA (48, 222-224).  These findings, 
in combination with the data presented here, underscore the concept that dietary ALA, 
unless markedly increased, is not an adequate substitute for dietary DHA. 
Electroretinography 
 Numerous studies have evaluated the effects of breast milk or n-3 LCPUFA-
supplemented formula on retinal development in neonatal humans and primates (5, 51, 
112-127, 135-143).  Although the debate regarding benefits to term infants is ongoing, the 
evidence for preterm infants seems to be more conclusive.  Studies in humans and primates 
indicate that LCPUFA synthesis may be more active in late-term and premature fetuses 
than in older neonates (29, 238).  All puppies in this study were born at full-term, and all 
received milk, rather than formula, during suckling.  Nonetheless, beneficial effects of 
dietary n-3 PUFA on ERG response were seen in the puppies in the present study.   
 ERG data obtained at the 8th light intensity was used for analysis of all ERG 
parameters because the highest (10th) intensity is known to saturate the b-wave response in 
canines.  Such a saturation effect could possibly mask measurable differences in retinal 
function amongst diet groups.   
 The descending segment of the a-wave represents photoreceptor activity, whereas 
the b-wave is the composite post-synaptic response of the bipolar and Müller cells (111, 
232, 239).  The ä parameter is related to the time-course of activation for the 
phosphodiesterase cascade in the ROS (232).   
Diau et al. reported in 4-wk old baboons that improvement of the b-wave response 
occurs independently of retinal DHA content and that “DHA per se is not the limiting 
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factor in the development of the b-amplitude in formula-fed neonates (140).”  Although 
RBC DHA data in this study were not reliable, differences due to diet appeared to exist 
between the Lo/Hi and Lo/Lo groups, while the differences between the Lo/Hi and 
Lo/Mod groups were less pronounced.  However, the lowest b-amp was observed in the 
Lo/Mod puppies rather than the Lo/Lo puppies.  Thus, the data suggest that magnitude of 
the b-wave response in breast-fed canines may also be independent of retinal DHA content 
and that other factors may be involved.  Further studies, however, should be conducted, 
and reliable biomarkers of retinal DHA status are needed.   
Although DHA did not appear to affect b-wave amplitude in this study, modest 
differences were observed in the implicit times of the b-wave.  Puppies in the Hi/Lo group 
had significantly shorter bi when compared to the Lo/Lo and Lo/Mod groups.  The bi of the 
Lo/Hi group was not significantly different from any group, but was most similar to that of 
the Hi/Lo puppies.  A reduction in bi may indicate increased efficiency of post-synaptic 
signal transduction of the visual response in the presence of increased retinal DHA. 
Puppies in the Lo/Lo group had significantly poorer retinal function as measured 
by the a-amp and ai when compared to puppies in the Lo/Hi group.  Mean a-amp in the 
Hi/Lo puppies was not significantly different from the Lo/Hi group, but was superior to 
both the Lo/Mod and Lo/Lo groups.  Although the best rod response (highest a-amp, 
lowest ai) occurred in those animals that received the highest amounts of dietary DHA 
during suckling, it was not significantly better than the rod response of animals fed a diet 
markedly rich in ALA.  Similarly, no difference in rod photoreceptor function was found 
in monkeys fed either 8% ALA or 0.6% DHA (136) or between monkeys fed either ALA 
as the sole n-3 PUFA or a combination of AA and DHA (139).  Furthermore, a study in 
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guinea pigs reported the highest ERG amplitudes in the group fed ALA only rather than in 
the group fed ALA in combination with n-3 LCPUFA (240).  Thus, it can be concluded 
from the data that gestation diets containing 0.55% DM DHA and milk containing 2.5 
relative% DHA are sufficient to effect increased photoreceptor activity in young canines.  
Additionally, it seems that gestation diets and milk high in ALA are able to achieve 
adequate DHA synthesis and neural enrichment such that photoreceptor activity is at least 
moderately improved.  However, the formulation of high-ALA diets, such as the one in 
this study, may be of little practical use due to the undesirable odor and lowered 
palatability associated with it. 
 A decrease in the ä parameter is indicative of a reduction in the initial amplification 
cascade, which is induced when a photon is absorbed by rhodopsin (140).  Therefore, a 
higher ä represents an increase in the initial amplification.  Although a distinction cannot 
be made as to whether such an increase means an increase in rhodopsin content or an 
increased efficiency of photon absorption, greater amplification demonstrates a favorable 
response when the overall value is elevated.  In light of the significantly higher value of ä 
from the Lo/Hi puppies, it can be concluded that DHA conveys a beneficial effect (i.e., an 
increase) on the initial amplification of the photoreceptor response. 
A novel parameter devised in this study is the threshold intensity, i.e. the light 
intensity at which the initial a-wave was observed.  Puppies that consumed the highest 
amount of n-3 LCPUFA (Lo/Hi) elicited the earliest photoreceptor response, which was 
significantly lower than those of the Lo/Lo and Hi/Lo groups, but not different from the 
Lo/Mod group.  These data indicate that puppies whose diets contained more n-3 LCPUFA 
had lower rod thresholds, i.e. greater rod sensitivity, than puppies in the other groups.  This 
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is a possible consequence of the higher dietary concentrations of n-3 LCPUFA in these two 
groups.  Studies in both term and preterm human infants have reported an association 
between DHA status and retinal sensitivity (241, 242).    
Taken together, the data from this study indicate an advantage of dietary DHA on 
retinal function in young canines.  Puppies consuming the highest concentrations of DHA 
in both milk and dry diet consistently demonstrated the greatest rod sensitivity (as 
measured by a-amp, ai, and It) and elicited the greatest increase in the amplification of the 
phosphodiesterase cascade.  Although visual performance in puppies fed the high ALA 
diet was not significantly lower than those fed DHA, it did not match the level of retinal 
function observed in the DHA-fed puppies.    
Erythrocyte DHA has been used as a marker for retinal and cortical DHA status 
(140), although the usefulness of this marker has been challenged (243).  Gibson, et al. 
reported poor correlation (r2=0.16) between erythrocyte and brain DHA in piglets and in 
post-mortem human infants (243).  They also declared the relationship between plasma and 
brain DHA to be non-existent.  In the present study, RBC data was insufficient to make 
either reliable estimates of retinal DHA or correlations of RBC DHA with retinal function.  
However, in four-week old baboon neonates, retinal tissue DHA status was most closely 
associated with a-wave parameters (140).  Additionally, retinal response was optimized in 
breast-fed or DHA-supplemented formula-fed compared to non-supplemented infants 
(140).  Thus, when data from these and the present studies are collectively considered, the 
likelihood of dietary DHA in canines resulting in retinal enrichment and its associated 
improvement in ERG-related measures helps to confirm and extend the importance of 
DHA in fetal and neonatal development among mammalian species.  In addition, new data 
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on the relationship of dietary PUFA and milk fatty acid composition will aid in the 
development of the most appropriate diets for gestation and lactation. 
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CHAPTER VI 
 
SUMMARY AND CONCLUSIONS 
  Long-chain polyunsaturated fatty acids are essential for proper growth and neural 
development in mammalian neonates.  Although evidence exists which supports the 
concept that neonates can synthesize n-3 LCPUFA, namely DHA, from ALA, it remains 
uncertain whether or not such conversion is sufficient to meet the demands of rapidly 
developing neural tissues.  Thus, because placental transfer is the only means of n-3 
LCPUFA delivery to the fetus, and because maternal milk is the sole exogenous source of 
n-3 LCPUFA for the newborn, maternal dietary n-3 LCPUFA intake during gestation and 
lactation could profoundly impact the n-3 LCPUFA status, and subsequent development, 
of both the fetus and the neonate.   
The objectives of this research were to investigate the effects of dietary ALA and 
n-3 LCPUFA on the following:  1) plasma PL fatty acid composition of adult canines 
during the gestation and lactation periods; 2) fatty acid composition of canine milk; 3) 
plasma PL fatty acid composition of canine neonates during the suckling and post-
weaning periods; 4) retinal development and function in 12-wk-old canine neonates.   
 In this study adult dogs were fed one of four experimental diets, which contained 
varying ratios of ALA to n-3 LCPUFA.  The combinations of ALA and n-3 LCPUFA 
content were:  low ALA/low n-3 LCPUFA (Lo/Lo); low ALA/moderate n-3 LCPUFA 
(Lo/Mod); low ALA/high n-3 LCPUFA (Lo/Hi); high ALA/low n-3 LCPUFA (Hi/Lo).  
Adult dogs were maintained on their randomly assigned diets for the entirety of gestation 
and lactation.  Following parturition, neonates were reared on mother’s milk until the 
time of weaning, at which point they were transitioned to the same dry experimental diet 
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as their mother had consumed.  The major findings of this study can be summarized as 
follows:   
1) The modification of dietary n-3 and n-6 fatty acid contents in canine diets 
resulted in altered lipid metabolism during gestation and lactation.  The plasma 
phospholipid (PL) contents of nearly all PUFA varied in a dose-dependent 
manner as a function of their dietary concentrations.  Despite large dietary 
differences in LA, no enrichment of AA occurred in the plasma PL fraction.  
Moreover, when compared with early gestation, plasma AA during lactation was 
significantly reduced in all diet groups.  Such an effect may reflect a channeling 
of AA to the mammary tissue for incorporation into the milk, which would assure 
delivery of this fatty acid to the growing newborn. Additionally, the plasma PL 
fatty acid data from this study confirmed the ability of adult canines to convert 
ALA to both EPA and DPA; however, only minimal synthesis of DHA occurred 
in response to high dietary ALA.  These results suggest a reduced capacity for 
DHA synthesis in older dogs.  
 
2) Enriching canine gestation/lactation diets with LA and ALA does not result in 
the enrichment of either AA or DHA in the milk. This observation suggests that 
the biosynthetic pathways specifically relating to desaturation and chain 
elongation of milk lipids are poorly developed in canine mammary tissue or that 
these pathways are competitively inhibited in the presence of either small dietary 
amounts of LCPUFA or their existing tissue stores.  In either case, dietary 
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supplementation of canine gestation/lactation diets with LA or ALA is an 
ineffective means of increasing milk AA and DHA content. 
 
3) Not only are canine neonates capable of converting ALA to DHA, but their 
synthetic capacity is greater during the suckling period when compared with the 
post-weaning period.  These results, in combination with the observed lack of 
DHA synthesis in adult dogs, suggest that neonatal canines may preferentially 
synthesize DHA at a time of life in which demand is especially high.  It is 
possible that peroxisomal metabolism in young dogs is increased compared to 
adults, whereby DPA is more readily converted to DHA.    
 
4) Canine neonates reared on a diet of milk containing 2.5 relative % DHA in 
combination with an experimental diet containing 0.55% DM DHA displayed 
superior photoreceptor function, that is, greater rod sensitivity, when compared to 
those on a low ALA/low n-3 LCPUFA diet.  Additionally, it seems that gestation 
diets and milk high in ALA are able to achieve adequate DHA synthesis and 
neural enrichment such that photoreceptor activity is at least moderately 
improved.  However, the plasma enrichment and photoreceptor function of dogs 
reared on this diet did not match that of the dogs fed the low ALA/high n-3 
LCPUFA diet. 
  
The findings of this research underscore the importance of providing n-3 
LCPUFA, rather than ALA, in the canine gestation/lactation diet as a means of enriching 
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milk with DHA.  Furthermore, dietary n-3 LCPUFA was more effective than ALA for the 
enrichment of plasma PL DHA during the developmental period in neonatal canines.  In 
addition, dietary DHA appears to be related to improved visual performance in 
developing canids.  Although a diet high in ALA was able to effect moderate 
improvements in ERG parameters when compared to a low ALA/low n-3 LCPUFA diet, 
visual function did not equal that of dogs fed higher amounts of dietary DHA.  This 
reinforces the notion that dietary ALA, unless exceedingly high, is not an adequate 
substitute for DHA.  Moreover, the formulation of high-ALA diets, such as the one in this 
study, may be of little practical use due to the undesirable odor and lowered palatability 
associated with it. 
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APPENDIX A 
TABLE A-I 
 
BODY WEIGHTS* OF ADULT DOG
 
DAY 
DIETS       DOG G0 G7 G14 G28 G42
Anne      23.5 23.8 23.8 23.0 23.7
Doris      18.2 17.9 17.8 17.4 18.8
Lo/Lo 
Alexa      24.0 23.8 23.4 22.0 25.6
Bambi      22.5 23.0 23.5 22.2 23.3
Belle      22.3 21.3 23.6 22.1 25.5
Hi/Lo 
Dolly      22.5 22.8 25.1 23.2 26.8
Brandi      21.4 21.2 21.2 20.7 23.3
Bonnie      21.0 22.9 22.7 20.3 23.7
Lo/Mod 
Bethany      22.9 22.5 24.2 23.2 25.3
Bettina      24.6 24.5 24.5 24.2 26.5
Dana      20.9 20.5 20.0 19.4 23.9
Lo/Hi 
Agnes      19.6 19.2 19.8 18.0 17.6
*Body weights are in kilograms.S 
    G56 L7 L14 L28
    28.9 22.2 23.1 22.8
    22.6 19.1 19.6 19.2
    297 21.8 22.4 22.2
    26.2 18.1 18.2 15.1
    29.9 24.2 25.5 22.1
    29.9 24.2 24.2 24.3
    26.9 21.3 24.1 25.0
    26.7 20.7 21.8 20.9
    27.3 23.1 23.0 24.7
    31.4 23.6 25.1 24.3
    26.1 21.9 23.2 23.2
    20.1 15.8 16.4 16.7
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TABLE A-II 
 
AVERAGE LITTER BODY WEIGHTS* OF PUPPIES 
 
DAY 
DIETS           LITTER 0 7 14 21 28 42 56 70 84
N 0.43 (8)  0.49 (8) 0.73 (8) 0.98 (8) 1.60 (8) 3.56 (8) 5.54 (8)  7.20 (8) 9.20(8)  
O 0.41 (6) 0.70 (6) 1.08 (6) 1.56 (6)  2.26 (6) 3.89 (6) 5.74 (6) 7.85 (4) 10.00 (4) 
Lo/Lo 
V 0.40 (10) 0.61 (10) 0.85(10) 1.16 (10) 1.79 (10) 3.38(10) 5.13 (10) 6.56 (7) 9.29 (7) 
S 0.36 (10) 0.47 (10) 0.61(10) 0.92 (10) 2.10 (10) 3.71 (10) 5.25 (10) 7.20 (7) 9.12 (7) 
U 0.48 (7)  0.62 (7) 0.91 (7) 1.02 (7) 1.25 (7) 2.58 (7) 3.59 (7) 5.50 (3) 7.00 (3) 
Hi/Lo 
W 0.39 (8) 0.51 (8) 0.88 (8) 1.24 (8) 1.56 (8) 2.98 (8) 4.33 (8) 6.53 (8) 8.51 (8) 
M 0.51 (7) 0.82 (7) 1.26 (7) 1.83 (7) 2.67 (7) 4.20 (7) 6.55 (7) 7.42 (5) 10.40 (5) 
P 0.35 (8) 0.51 (8) 0.79 (8) 1.10 (8) 1.66 (8) 3.18 (8) 5.18 (8) 6.32 (6) 7.25 (6) 
Lo/Mod 
Q 0.48 (7) 0.76 (7) 1.12 (7) 1.59 (7) 2.32 (7) 3.59 (7) 5.61 (7) 6.79 (2) 8.66 (2) 
K 0.49 (8) 0.71 (8) 1.02 (8) 1.37 (8) 1.93 (8) 3.30 (8) 4.64 (8) 7.22 (5) 8.02 (5) 
R 0.45 (4) 0.70 (4) 1.14 (4) 1.61 (4) 2.49 (4) 4.24 (4) 6.04 (4) 7.06 (2) 10.20 (2) 
Lo/Hi 
T 0.39 (6) 0.52 (6) 0.74 (6) 1.02 (6) 1.71 (6) 3.13 (6) 4.80 (6) 6.55 (3) 8.70 (3) 
*Body weights are in kilograms.  Values in parentheses indicate litter size.
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TABLE B-I 
 
MATERNAL DIET FATTY ACID CONCENTRATION 
(% dry matter basis)* 
 
Diet  Fatty Acid Lo/Lo Lo/Mod Lo/Hi Hi/Lo 
Saturated  6.02 5.46 6.95 2.55 
Monounsaturated  6.55 6.14 6.17 4.22 
18:2n-6 1.75 2.61 1.16 3.5 
20:4n-6 0.02 0.03 0.05 0.02 
18:3n-3 0.14 0.29 0.2 6.82 
20:5n-3 0.02 0.19 0.5 0.02 
22:5n-3 0.02 0.05 0.11 0.02 
22:6n-3 0.02 0.19 0.55 0.02 
%total fatty acids 14.54 14.96 15.69 17.17 
%total dietary fat 15.33 15.90 16.10 17.47 
*The diets are designated based on their ALA/n-3 LCPUFA contents.  For details see text.  
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TABLE B-II 
MATERNAL DIET NUTRIENT PROFILES  
(% dry matter basis)*
 
Diet  Fatty Acid Lo/Lo Lo/Mod Lo/Hi Hi/Lo 
Crude protein 30.7 30.4 29.9 31.4 
Fat 15.3 15.8 16.1 17.5 
Nitrogen-free extract 47.8 47.5 47.9 44.6 
Ash 6.2 6.2 6.1 6.5 
Energy (kcal/g) 5.1 5.1 5.2 5.0 
* Ingredients of each diet included Supro 620®,Brewers milled rice, taurine, potassium 
chloride, vitamin Super Premix, dehulled soybean meal, poultry by-product meal, pea 
fiber, dry calcium chloride, dicalcium phosphate, NaCl, mineral premix, liquid choline 
chloride, vitamin E 50%, safflower oil, and linseed oil, beef tallow, or Menhaden fish oil. 
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TABLE B-III 
 
COMPLETE FATTY ACID PROFILE OF EXPERIMENTAL DIETS 
(expressed as % fatty acids) 
Fatty Acid Lo/Lo Hi/Lo Lo/Mod Lo/Hi 
13:0 <0.10 <0.10 <0.10 <0.10 
14:0 2.32 0.34 2.94 4.45 
14:1 0.47 <0.10 0.32 0.39 
15:0 0.37 <0.10 0.39 0.46 
15:1 <0.10 <0.10 <0.10 <0.10 
16:0 22.70 9.45 21.00 23.70 
16:1 2.97 0.57 4.02 5.54 
17:0 1.11 0.18 0.84 0.90 
17:1 <0.10 <0.10 <0.10 <0.10 
18:0 14.2 5.18 10.60 10.80 
18:1 40.31 23.95 34.42 32.55 
18:2 11.67 20.00 16.69 6.83 
18:3 0.89 39.00 1.80 1.05 
19:0 0.18 <0.10 0.12 0.12 
20:0 0.16 0.18 0.21 0.14 
20:1 0.23 0.14 0.38 0.61 
20:2 <0.10 <0.10 <0.10 0.18 
20:3 <0.10 <0.10 <0.10 0.21 
20:4 0.12 <0.10 0.20 0.31 
20:5 <0.10 <0.10 1.22 2.83 
21:0 <0.10 <0.10 <0.10 <0.10 
22:0 <0.10 0.16 0.13 <0.10 
22:1 <0.10 <0.10 <0.10 0.10 
22:2 <0.10 <0.10 <0.10 <0.10 
22:5 <0.10 <0.10 0.26 0.59 
22:6 <0.10 <0.10 1.19 3.07 
23:0 <0.10 <0.10 <0.10 <0.10 
24:0 <0.10 0.13 0.10 <0.10 
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